methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amine
Title | Journal |
---|---|
Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay. | Toxicology in vitro : an international journal published in association with BIBRA 20180301 |
Why are most phospholipidosis inducers also hERG blockers? | Archives of toxicology 20171201 |
Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs. | Toxicological sciences : an official journal of the Society of Toxicology 20150601 |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | Chemical research in toxicology 20150518 |
Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor. | ACS medicinal chemistry letters 20130613 |
A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships. | Bioorganic & medicinal chemistry letters 20130301 |
4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20121201 |
Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain. | Pain practice : the official journal of World Institute of Pain 20121101 |
Automated measurement of spontaneous pain-associated limb movement and drug efficacy evaluation in a rat model of neuropathic pain. | European journal of pain (London, England) 20121101 |
Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment. | Journal of psychopharmacology (Oxford, England) 20121101 |
Evaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale: pooled analysis of data from six randomized, double-blind, placebo-controlled clinical studies. | International clinical psychopharmacology 20121101 |
Prediction of longer-term outcome of treatment-resistant depression in tertiary care. | The British journal of psychiatry : the journal of mental science 20121101 |
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease. | Expert opinion on pharmacotherapy 20121101 |
Painful diabetic polyneuropathy: approach to diagnosis and management. | The Clinical journal of pain 20121001 |
A rodent model of premenstrual dysphoria: progesterone withdrawal induces depression-like behavior that is differentially sensitive to classes of antidepressants. | Behavioural brain research 20121001 |
Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: a case report. | Journal of clinical psychopharmacology 20121001 |
A case of severe hyponatremia induced by duloxetine and ziprasidone. | Chinese medical journal 20121001 |
Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats. | European journal of pharmacology 20120915 |
Development of a rapid and sensitive SPE-LC-MS/MS method for the simultaneous estimation of fluoxetine and olanzapine in human plasma. | Biomedical chromatography : BMC 20120901 |
Acute massive pulmonary thromboembolism due to acute intoxication by duloxetine: a case report. | Cardiovascular toxicology 20120901 |
Differential BDNF responses of triple versus dual reuptake inhibition in neuronal and astrocytoma cells as well as in rat hippocampus and prefrontal cortex. | Journal of molecular neuroscience : MN 20120901 |
Tolerability aspects in duloxetine-treated patients with depression: Should one use a lower starting dose in clinical practice? | Expert opinion on drug safety 20120901 |
Duloxetine for the management of pain in older adults with knee osteoarthritis: randomised placebo-controlled trial. | Age and ageing 20120901 |
Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain. | Journal of psychiatric research 20120901 |
A 9-week randomized trial comparing a chronotherapeutic intervention (wake and light therapy) to exercise in major depressive disorder patients treated with duloxetine. | The Journal of clinical psychiatry 20120901 |
Study of emotional and cognitive impairments in mononeuropathic rats: effect of duloxetine and gabapentin. | Pain 20120801 |
Preclinical discovery of duloxetine for the treatment of depression. | Expert opinion on drug discovery 20120801 |
Clinical characteristics of 150 consecutive fibromyalgia patients attending an Australian public hospital clinic. | International journal of rheumatic diseases 20120801 |
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. | PLoS computational biology 20120801 |
Duloxetine blocks cloned Kv4.3 potassium channels. | Brain research 20120723 |
Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120701 |
Identification of 5-HT(2C) mediated mechanisms involved in urethral sphincter reflexes in a guinea-pig model of urethral function. | BJU international 20120701 |
A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD). | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120701 |
Assessing carrageenan-induced locomotor activity impairment in rats: comparison with evoked endpoint of acute inflammatory pain. | European journal of pain (London, England) 20120701 |
The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model. | Anesthesia and analgesia 20120701 |
Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia. | The Journal of pharmacology and experimental therapeutics 20120701 |
Determination and validation of duloxetine hydrochloride in capsules by HPLC with pre-column derivatization and fluorescence detection. | Journal of chromatographic science 20120701 |
A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. | International clinical psychopharmacology 20120701 |
Analgesic antidepressants promote the responsiveness of locus coeruleus neurons to noxious stimulation: implications for neuropathic pain. | Pain 20120701 |
Duloxetine use in chronic low back pain: treatment patterns and costs. | PharmacoEconomics 20120701 |
Pregabalin for the treatment of fibromyalgia. | Expert opinion on pharmacotherapy 20120701 |
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression. | The Journal of clinical psychiatry 20120701 |
Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study. | Pain practice : the official journal of World Institute of Pain 20120601 |
Comparative effectiveness in pain-related outcomes and health care utilizations between veterans with major depressive disorder treated with duloxetine and other antidepressants: a retrospective propensity score-matched comparison. | Pain practice : the official journal of World Institute of Pain 20120601 |
Agomelatine-induced akathisia with concomitant duloxetine medication: a case report. | Pharmacopsychiatry 20120601 |
Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial. | Annals of the rheumatic diseases 20120601 |
Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. | Pain 20120601 |
A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy. | Journal of pain & palliative care pharmacotherapy 20120601 |
Emerging analgesic drugs for Parkinson's disease. | Expert opinion on emerging drugs 20120601 |
Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. | Depression and anxiety 20120601 |
Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine. | Clinical drug investigation 20120601 |
Re: Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial. | The Journal of urology 20120601 |
[Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. | Schmerz (Berlin, Germany) 20120601 |
Advanced oxidation treatment and photochemical fate of selected antidepressant pharmaceuticals in solutions of Suwannee River humic acid. | Journal of hazardous materials 20120530 |
Development and validation of a liquid chromatography-tandem mass spectrometry assay for hair analysis of atomoxetine and its metabolites: Application in clinical practice. | Forensic science international 20120510 |
Concise enantioselective synthesis of duloxetine via direct catalytic asymmetric aldol reaction of thioamide. | The Journal of organic chemistry 20120504 |
[Fibromyalgia and psychiatry: 35 years later… what's new?]. | Presse medicale (Paris, France : 1983) 20120501 |
Does pain improve earlier than mood in depressed patients with painful physical symptoms treated with duloxetine? | Pharmacopsychiatry 20120501 |
Exploratory translational modeling approach in drug development to predict human brain pharmacokinetics and pharmacologically relevant clinical doses. | Drug metabolism and disposition: the biological fate of chemicals 20120501 |
The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function. | Pharmacology, biochemistry, and behavior 20120501 |
Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram. | Journal of psychiatric research 20120501 |
Antidepressants and the relief of osteoarthritic pain - findings from a study examining adjunctive duloxetine. | International journal of clinical practice 20120501 |
Changes in the prescription of psychotropic drugs in the palliative care of advanced cancer patients over a seven-year period. | Journal of pain and symptom management 20120501 |
A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion. | Journal of clinical anesthesia 20120501 |
Treatments for diabetic neuropathy. | Journal of the peripheral nervous system : JPNS 20120501 |
A framework for fibromyalgia management for primary care providers. | Mayo Clinic proceedings 20120501 |
Italian guidelines for primary headaches: 2012 revised version. | The journal of headache and pain 20120501 |
Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin. | Anticancer research 20120501 |
Chronic pain following spinal cord injury. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20120430 |
Predictors of pain medication selection among patients diagnosed with fibromyalgia. | Pain practice : the official journal of World Institute of Pain 20120401 |
Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120401 |
Prediction of human serotonin and norepinephrine transporter occupancy of duloxetine by pharmacokinetic/pharmacodynamic modeling in the rat. | The Journal of pharmacology and experimental therapeutics 20120401 |
Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery. | Heart, lung & circulation 20120401 |
Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain. | Pain 20120401 |
Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine. | Clinical therapeutics 20120401 |
A simple HPLC method for the simultaneous determination of two selective serotonin reuptake inhibitors and two serotonin-norepinephrine reuptake inhibitors in hair, nail clippings, and cerebrospinal fluid. | Journal of separation science 20120401 |
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. | Arthritis care & research 20120401 |
Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20120308 |
Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine. | Pain practice : the official journal of World Institute of Pain 20120301 |
Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial. | The International journal of eating disorders 20120301 |
Duloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form design. | AAPS PharmSciTech 20120301 |
Predictors of remission with placebo using an integrated study database from patients with major depressive disorder. | Current medical research and opinion 20120301 |
Generalized tonic-clonic seizure secondary to duloxetine poisoning: a short report with favorable out come. | Neurotoxicology 20120301 |
Delirium associated with duloxetine in a depressed patient with Alzheimer's dementia. | Psychiatry and clinical neurosciences 20120301 |
A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. | Clinical therapeutics 20120301 |
Rapid-onset hyponatremia induced by duloxetine in a middle-aged male with depression and somatic symptoms. | Psychiatry investigation 20120301 |
Suprathreshold duloxetine for treatment-resistant depression, anorexia nervosa binge-purging type, and obsessive-compulsive disorder: a case report. | Innovations in clinical neuroscience 20120301 |
Self-reported antidepressant use among depressed, low-income homebound older adults: class, type, correlates, and perceived effectiveness. | Brain and behavior 20120301 |
Determination of atomoxetine and its metabolites in conventional and non-conventional biological matrices by liquid chromatography-tandem mass spectrometry. | Journal of pharmaceutical and biomedical analysis 20120223 |
Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120201 |
Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis. | The Journal of rheumatology 20120201 |
Frontal regional homogeneity increased and temporal regional homogeneity decreased after remission of first-episode drug-naïve major depressive disorder with panic disorder patients under duloxetine therapy for 6 weeks. | Journal of affective disorders 20120201 |
Treatment with duloxetine in adults and the incidence of cardiovascular events. | Journal of clinical psychopharmacology 20120201 |
Quantitative method validation for the analysis of 27 antidepressants and metabolites in plasma with ultraperformance liquid chromatography-tandem mass spectrometry. | Therapeutic drug monitoring 20120201 |
An open-label safety and pharmacokinetics study of duloxetine in pediatric patients with major depression. | Journal of child and adolescent psychopharmacology 20120201 |
Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. | Diabetes/metabolism research and reviews 20120201 |
Peripheral nerve toxic effects of nitrofurantoin. | Archives of neurology 20120201 |
Diabetic peripheral neuropathy in type 2 diabetes mellitus in Korea. | Diabetes & metabolism journal 20120201 |
[Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram]. | L'Encephale 20120201 |
Efficacy of antidepressants as analgesics: a review. | Journal of clinical pharmacology 20120101 |
Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine. | Pain practice : the official journal of World Institute of Pain 20120101 |
Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate. | Psychological medicine 20120101 |
A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression. | Journal of affective disorders 20120101 |
Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care. | Journal of medical economics 20120101 |
Early discontinuation and suboptimal dosing of duloxetine treatment in patients with major depressive disorder: analysis from a US third-party payer perspective. | Journal of medical economics 20120101 |
Persistent genital arousal disorder: successful treatment with duloxetine and pregabalin in two cases. | The journal of sexual medicine 20120101 |
A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode. | International clinical psychopharmacology 20120101 |
Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico. | Journal of medical economics 20120101 |
Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems. | Pain research and treatment 20120101 |
Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo. | Current medical research and opinion 20120101 |
The clinical concept of fibromyalgia as a changing paradigm in the past 20 years. | Pain research and treatment 20120101 |
Clinically significant drug interactions with newer antidepressants. | CNS drugs 20120101 |
Fibromyalgia and depression. | Pain research and treatment 20120101 |
The prevalence of fibromyalgia in other chronic pain conditions. | Pain research and treatment 20120101 |
Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis. | BMC neuroscience 20120101 |
Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol. | Human psychopharmacology 20120101 |
The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease. | Parkinson's disease 20120101 |
Disposable screen-printed sensors for determination of duloxetine hydrochloride. | Chemistry Central journal 20120101 |
Reversible ptosis probably related to duloxetine use. | General hospital psychiatry 20120101 |
Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review. | Cost effectiveness and resource allocation : C/E 20120101 |
A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? | Postgraduate medicine 20120101 |
A community-integrated home based depression intervention for older African Americans: [corrected] description of the Beat the Blues randomized trial and intervention costs. | BMC geriatrics 20120101 |
Psychiatric symptoms of patients with primary mitochondrial DNA disorders. | Behavioral and brain functions : BBF 20120101 |
Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials. | International journal of endocrinology 20120101 |
The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective. | Journal of medical economics 20120101 |
Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy. | Indian journal of pharmacology 20120101 |
A multicomponent yoga-based, breath intervention program as an adjunctive treatment in patients suffering from generalized anxiety disorder with or without comorbidities. | International journal of yoga 20120101 |
Neuroimmune endocrine effects of antidepressants. | Neuropsychiatric disease and treatment 20120101 |
A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. | BMC musculoskeletal disorders 20120101 |
Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico. | Reumatologia clinica 20120101 |
Healthcare utilization among patients with depression before and after initiating duloxetine in the United Kingdom. | Journal of medical economics 20120101 |
Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study. | BMC neurology 20120101 |
Translational investigation and treatment of neuropathic pain. | Molecular pain 20120101 |
Adoption of new drugs by physicians: a survival analysis. | BMC health services research 20120101 |
Effects of arterial cannulation stress on regional cerebral blood flow in major depressive disorder. | Scientific reports 20120101 |
Fibromyalgia syndrome and spa therapy: myth or reality? | Clinical medicine insights. Arthritis and musculoskeletal disorders 20120101 |
Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN). | PloS one 20120101 |
Resource utilization and costs before and after total joint arthroplasty. | BMC health services research 20120101 |
Antiallodynic effect of herbal medicine yokukansan on peripheral neuropathy in rats with chronic constriction injury. | Evidence-based complementary and alternative medicine : eCAM 20120101 |
Current and future options for the management of phantom-limb pain. | Journal of pain research 20120101 |
Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. | BMJ open 20120101 |
The analgesic effect of different antidepressants combined with aspirin on thermally induced pain in Albino mice. | The Libyan journal of medicine 20120101 |
Accumulation of an antidepressant in vesiculogenic membranes of yeast cells triggers autophagy. | PloS one 20120101 |
Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups. | Journal of pain research 20120101 |
Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. | Frontiers in psychology 20120101 |
Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials. | PloS one 20120101 |
Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials. | Pain research and treatment 20120101 |
New artificial urinary sphincter devices in the treatment of male iatrogenic incontinence. | Advances in urology 20120101 |
Duloxetine inhibits effects of MDMA ('ecstasy') in vitro and in humans in a randomized placebo-controlled laboratory study. | PloS one 20120101 |
Sympathetic blocks provided sustained pain relief in a patient with refractory painful diabetic neuropathy. | Case reports in anesthesiology 20120101 |
Potential for Cell-Transplant Therapy with Human Neuronal Precursors to Treat Neuropathic Pain in Models of PNS and CNS Injury: Comparison of hNT2.17 and hNT2.19 Cell Lines. | Pain research and treatment 20120101 |
Medical marijuana: clearing away the smoke. | The open neurology journal 20120101 |
Treatment-resistant Schizophrenia: Evidence-based Strategies. | Mens sana monographs 20120101 |
Treatment-resistant depression: therapeutic trends, challenges, and future directions. | Patient preference and adherence 20120101 |
Pharmacological management of binge eating disorder: current and emerging treatment options. | Therapeutics and clinical risk management 20120101 |
Stress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatment. | PloS one 20120101 |
Predictors of Treatment with Duloxetine or Venlafaxine XR among Adult Patients Treated for Depression in Primary Care Practices in the United Kingdom. | Depression research and treatment 20120101 |
Duloxetine in the treatment of adolescents with somatoform disorders: a report of two cases. | Actas espanolas de psiquiatria 20120101 |
Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study. | Clinical neuropharmacology 20120101 |
The effect of duloxetine treatment on cognition in patients with fibromyalgia. | Psychosomatic medicine 20120101 |
Duloxetine in the management of chronic musculoskeletal pain. | Therapeutics and clinical risk management 20120101 |
Acute hepatic failure involving duloxetine hydrochloride. | The Journal of neuropsychiatry and clinical neurosciences 20120101 |
Predictors of duloxetine adherence and persistence in patients with fibromyalgia. | Journal of pain research 20120101 |
Heart failure assocated with pregabalin. | Pain physician 20120101 |
Depression treatment with duloxetine and reduction of inability to work. | Depression research and treatment 20120101 |
Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study. | The Clinical journal of pain 20120101 |
Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain. | Pain research and treatment 20120101 |
Warfarin: pharmacological profile and drug interactions with antidepressants. | Einstein (Sao Paulo, Brazil) 20120101 |
Use of select medications prior to duloxetine initiation among commercially-insured patients. | Journal of pain research 20120101 |
Duloxetine versus other anti-depressive agents for depression. | The Cochrane database of systematic reviews 20120101 |
Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms. | Cancer 20111215 |
Second-generation antidepressants for seasonal affective disorder. | The Cochrane database of systematic reviews 20111207 |
Polymorphism and a metastable solvate of duloxetine hydrochloride. | Molecular pharmaceutics 20111205 |
Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background? | Journal of affective disorders 20111201 |
Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer. | Journal of pain and symptom management 20111201 |
A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia. | Seminars in arthritis and rheumatism 20111201 |
Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial. | Current medical research and opinion 20111201 |
Case scenario: opioid association with serotonin syndrome: implications to the practitioners. | Anesthesiology 20111201 |
Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database. | Drug safety 20111201 |
Desvenlafaxine in the treatment of major depressive disorder. | Expert opinion on pharmacotherapy 20111201 |
[Therapeutic advances in pharmaceutical treatment of neuropathic pain]. | Revue neurologique 20111201 |
Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses. | Archives of general psychiatry 20111201 |
Antidepressants in pregnancy: a review of commonly prescribed medications. | Obstetrical & gynecological survey 20111201 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
Lumbar plexopathy caused by metastatic tumor, which was mistaken for postoperative femoral neuropathy. | The Korean journal of pain 20111201 |
Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. | The Journal of clinical psychiatry 20111201 |
A lifespan view of anxiety disorders. | Dialogues in clinical neuroscience 20111201 |
Pharmacotherapy of anxiety disorders: a critical review. | Dialogues in clinical neuroscience 20111201 |
Pharmacotherapy for anxiety disorders in children and adolescents. | Dialogues in clinical neuroscience 20111201 |
Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. | Current neuropharmacology 20111201 |
Duloxetine's modest short-term influences in subcortical structures of first episode drug-naïve patients with major depressive disorder and panic disorder. | Psychiatry research 20111130 |
Applying medicinal chemistry transformations and multiparameter optimization to guide the search for high-quality leads and candidates. | Journal of chemical information and modeling 20111128 |
Acute and chronic pain management in fibromyalgia: updates on pharmacotherapy. | American journal of therapeutics 20111101 |
Adverse reactions to duloxetine in depression. | Expert opinion on drug safety 20111101 |
Neoteric pharmacotherapeutic targets in fibromyalgia. | Expert opinion on therapeutic targets 20111101 |
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. | International clinical psychopharmacology 20111101 |
Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients. | Pharmacopsychiatry 20111101 |
Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion. | Pharmacopsychiatry 20111101 |
Depression screening and treatment among nonpregnant women of reproductive age in the United States, 1990-2010. | Preventing chronic disease 20111101 |
Duloxetine in the acute and continuation treatment of major depressive disorder. | Expert review of neurotherapeutics 20111101 |
Dosing patterns for duloxetine and predictors of high-dose prescriptions in patients with major depressive disorder: analysis from a United States third-party payer perspective. | Clinical therapeutics 20111101 |
Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period. | International journal of psychiatry in clinical practice 20111101 |
Association of catechol-O-methyltransferase variants with duloxetine response in major depressive disorder. | Psychiatry research 20111030 |
Reversible time-dependent inhibition of cytochrome P450 enzymes by duloxetine and inertness of its thiophene ring towards bioactivation. | Toxicology letters 20111030 |
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20111001 |
Fibromyalgia: mechanisms, current treatment and animal models. | Current pharmaceutical biotechnology 20111001 |
Sleep disorders and fibromyalgia. | Current pain and headache reports 20111001 |
Early improvement in pain predicts pain response at endpoint in patients with fibromyalgia. | The journal of pain : official journal of the American Pain Society 20111001 |
Short-term duloxetine administration affects neural correlates of mood-congruent memory. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20111001 |
Pregabalin modulation of spinal and brainstem visceral nociceptive processing. | Pain 20111001 |
Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study. | Current medical research and opinion 20111001 |
A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms. | Current medical research and opinion 20111001 |
Effects of baseline depression severity on remission rates with duloxetine and placebo in anxious and nonanxious patients with major depression. | Journal of clinical psychopharmacology 20111001 |
Colleague interactions and new drug prescribing behavior: the case of the initial prescription of antidepressants in Taiwanese medical centers. | Social science & medicine (1982) 20111001 |
Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China. | Chinese medical journal 20111001 |
[Interactions between metoprolol and antidepressants]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110920 |
Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits. | Biological psychiatry 20110915 |
A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy. | British journal of pharmacology 20110901 |
Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy. | The International journal of neuroscience 20110901 |
Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. | The Journal of clinical endocrinology and metabolism 20110901 |
Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia. | Current medical research and opinion 20110901 |
Chemotherapy-induced peripheral neuropathy: prevention and treatment. | Clinical pharmacology and therapeutics 20110901 |
Effects of milnacipran, duloxetine and indomethacin, in polyarthritic rats using the Randall-Selitto model. | Behavioural pharmacology 20110901 |
Safety of electroconvulsive therapy-duloxetine combination. | The journal of ECT 20110901 |
A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. | The Australian and New Zealand journal of psychiatry 20110901 |
Duloxetine in the treatment of depression: an overview. | Central nervous system agents in medicinal chemistry 20110901 |
Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. | Gut and liver 20110901 |
Duloxetine-induced liver injury in patients with major depressive disorder. | Psychiatry investigation 20110901 |
[Conservative treatment of female urinary incontinence]. | La Revue du praticien 20110901 |
N,N-Dimethyl-3-oxo-3-(thio-phen-2-yl)propanaminium chloride. | Acta crystallographica. Section E, Structure reports online 20110901 |
Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure. | Current neuropharmacology 20110901 |
Differential conditioned fear response predicts duloxetine treatment outcome in male veterans with PTSD: a pilot study. | Psychiatry research 20110815 |
Efficacy and safety of duloxetine 60 mg and 120 mg daily in patients hospitalized for severe depression: a double-blind randomized trial. | The Journal of clinical psychiatry 20110801 |
Measurement-based care in psychiatric practice: a policy framework for implementation. | The Journal of clinical psychiatry 20110801 |
Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. | The journal of headache and pain 20110801 |
Is duloxetine more effective than amitriptyline for painful diabetic neuropathy? | Current diabetes reports 20110801 |
Postprostatectomy established stress urinary incontinence treated with duloxetine. | Urology 20110801 |
Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. | Brain, behavior, and immunity 20110801 |
Sodium oxybate for the treatment of fibromyalgia. | Expert opinion on pharmacotherapy 20110801 |
Duloxetine for depression and the incidence of hepatic events in adults. | Journal of clinical psychopharmacology 20110801 |
Erythema multiforme photoinduced by paroxetine and herpes simplex virus. | Photodermatology, photoimmunology & photomedicine 20110801 |
Pharmacotherapy of fibromyalgia. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110715 |
Highly enantioselective bioreduction of N-methyl-3-oxo-3-(thiophen-2-yl) propanamide for the production of (S)-duloxetine. | Biotechnology letters 20110701 |
Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases. | Current medical research and opinion 20110701 |
Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. | Mayo Clinic proceedings 20110701 |
Primary headaches in patients with generalized anxiety disorder. | The journal of headache and pain 20110601 |
Estimation of minimum clinically important difference for pain in fibromyalgia. | Arthritis care & research 20110601 |
Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain? | British journal of pharmacology 20110601 |
Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors. | Current medical research and opinion 20110601 |
Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine. | Current medical research and opinion 20110601 |
Phantom headache: pain-memory-emotion hypothesis for chronic daily headache? | The journal of headache and pain 20110601 |
Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation. | Muscle & nerve 20110601 |
Duloxetine use in painful conditions. | Expert opinion on pharmacotherapy 20110601 |
Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study. | International journal of psychiatry in clinical practice 20110601 |
A chemoenzymatic dynamic kinetic resolution approach to enantiomerically pure (R)- and (S)-duloxetine. | The Journal of organic chemistry 20110520 |
[Non-surgical treatment of female incontinence]. | MMW Fortschritte der Medizin 20110519 |
Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. | Neurology 20110517 |
Adherence and persistence with duloxetine and hospital utilization in patients with major depressive disorder. | International clinical psychopharmacology 20110501 |
Duloxetine: clinical pharmacokinetics and drug interactions. | Clinical pharmacokinetics 20110501 |
Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia. | Current medical research and opinion 20110501 |
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms. | Recent patents on CNS drug discovery 20110501 |
Duloxetine-induced tako-tsubo cardiomyopathy: implications for preventing a broken heart. | Southern medical journal 20110501 |
'Tako-tsubo' cardiomyopathy and duloxetine use. | Southern medical journal 20110501 |
Interaction between adalimumab with concurrent pregabalin and duloxetine administration in a psoriasis patient with diabetic peripheral neuropathy. | Cutis 20110501 |
[Because depression also hurts: duloxetine can help patients return to vitality]. | MMW Fortschritte der Medizin 20110407 |
[Interview with Dr. Heike-Ariane Washeim, Zirndorf, and Dr. Heiner Buschmann, Übach-Palenberg (interview by Abdol A. Ameri)]. | MMW Fortschritte der Medizin 20110407 |
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants. | Journal of affective disorders 20110401 |
A systematic review of duloxetine and venlafaxine in major depression, including unpublished data. | Acta psychiatrica Scandinavica 20110401 |
Treatment of diabetic sensory polyneuropathy. | Current treatment options in neurology 20110401 |
Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin. | Current medical research and opinion 20110401 |
A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial. | Diabetes care 20110401 |
Duloxetine transfer across the placenta during pregnancy and into milk during lactation. | Archives of women's mental health 20110401 |
Examining the use of tramadol hydrochloride as an antidepressant. | Experimental and clinical psychopharmacology 20110401 |
Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. | PM & R : the journal of injury, function, and rehabilitation 20110401 |
Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. | The Journal of clinical psychiatry 20110401 |
Evaluation of efficacy of duloxetine in stress urinary incontinence in women. | Indian journal of pharmacology 20110401 |
Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorder. | Human psychopharmacology 20110401 |
Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetine. | Human psychopharmacology 20110401 |
Fibromyalgia and sleep. | Best practice & research. Clinical rheumatology 20110401 |
Pharmacotherapy of fibromyalgia. | Best practice & research. Clinical rheumatology 20110401 |
Efficacy, safety and tolerability of duloxetine in idiopathic trigeminal neuralgia. | Journal of the Indian Medical Association 20110401 |
Subchronic duloxetine administration alters the extended amygdala circuitry in healthy individuals. | NeuroImage 20110315 |
Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. | BMJ (Clinical research ed.) 20110311 |
Tramadol increases extracellular levels of serotonin and noradrenaline as measured by in vivo microdialysis in the ventral hippocampus of freely-moving rats. | Neuroscience letters 20110303 |
A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy. | The international journal of neuropsychopharmacology 20110301 |
Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: a behavioural and pharmacological study. | European journal of pain (London, England) 20110301 |
Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancy. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110301 |
Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. | Rheumatology (Oxford, England) 20110301 |
Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder. | The journal of sexual medicine 20110301 |
Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. | International clinical psychopharmacology 20110301 |
Combination of lithium and duloxetine in 2 depressed patients refractory to duloxetine monotherapy. | Pharmacopsychiatry 20110301 |
Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine -- case report. | Pharmacopsychiatry 20110301 |
Burning mouth syndrome responsive to duloxetine: a case report. | Pain medicine (Malden, Mass.) 20110301 |
Hypogonadism and gynecomastia with duloxetine. | Pharmacopsychiatry 20110301 |
Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies. | International journal of clinical practice 20110301 |
Duloxetine-related panic attacks. | Psychiatria Danubina 20110301 |
Reinforcement of irritability during therapy with benzodiazepines. | Psychiatria Danubina 20110301 |
Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open-label study. | Human psychopharmacology 20110301 |
On the three-arm non-inferiority trial including a placebo with a prespecified margin. | Statistics in medicine 20110210 |
Is duloxetine useful for central neuropathic pain? | Pain 20110201 |
Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthases. | The Journal of pharmacology and experimental therapeutics 20110201 |
Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial. | Pain 20110201 |
Pseudohypoalgesia on the skin: a novel view on the paradox of pain perception in depression. | Journal of clinical psychopharmacology 20110201 |
Urinary incontinence in 2010: the evolution of SUI management. | Nature reviews. Urology 20110201 |
Atypical Stevens-Johnson syndrome in an adolescent treated with duloxetine. | Journal of child and adolescent psychopharmacology 20110201 |
Psychotropic medication use among elderly nursing home residents in Slovenia: cross-sectional study. | Croatian medical journal 20110201 |
It might be a big family but the pain remains-last chance saloon for selective 5-HT receptor ligands? | Current opinion in pharmacology 20110201 |
Effect of glibenclamide on antinociceptive effects of antidepressants of different classes. | Clinics (Sao Paulo, Brazil) 20110201 |
A case of venlafaxine-induced bruxism alleviated by duloxetine substitution. | Progress in neuro-psychopharmacology & biological psychiatry 20110115 |
Aripiprazole augmentation induced hypertension in major depressive disorder: a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20110115 |
Antidepressant use and colorectal cancer risk: a Danish population-based case-control study. | British journal of cancer 20110104 |
Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority Trial. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine. | Pain 20110101 |
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. | Pain practice : the official journal of World Institute of Pain 20110101 |
Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies. | Pain practice : the official journal of World Institute of Pain 20110101 |
Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care. | Pain practice : the official journal of World Institute of Pain 20110101 |
Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia. | Pain practice : the official journal of World Institute of Pain 20110101 |
Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase. | Basic & clinical pharmacology & toxicology 20110101 |
Novel antidepressants and panic disorder: evidence beyond current guidelines. | Neuropsychobiology 20110101 |
Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial. | European urology 20110101 |
Halothane-anesthetized rabbit: a new experimental model to test the effects of besipirdine and duloxetine on lower urinary tract function. | Urologia internationalis 20110101 |
Attributes of response in depressed patients switched to treatment with duloxetine. | International journal of clinical practice 20110101 |
Coma after overdose with duloxetine. | The Annals of pharmacotherapy 20110101 |
Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine. | Pain practice : the official journal of World Institute of Pain 20110101 |
Evidence-based interventional pain medicine according to clinical diagnoses. 18. Painful diabetic polyneuropathy. | Pain practice : the official journal of World Institute of Pain 20110101 |
Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine. | Pain practice : the official journal of World Institute of Pain 20110101 |
A meta-analysis of pain response in the treatment of fibromyalgia. | Pain practice : the official journal of World Institute of Pain 20110101 |
Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. | The British journal of psychiatry : the journal of mental science 20110101 |
Branch facial nerve trauma after superficial temporal artery biopsy: a case report. | Journal of medical case reports 20110101 |
Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder. | BMC psychiatry 20110101 |
Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. | Journal of neuroinflammation 20110101 |
Weight gain, obesity, and psychotropic prescribing. | Journal of obesity 20110101 |
Pathologic grooming behavior: facial dermatillomania. | Cutis 20110101 |
Effects of acupuncture on patients with fibromyalgia: study protocol of a multicentre randomized controlled trial. | Trials 20110101 |
Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series. | Annals of general psychiatry 20110101 |
Clinical and demographic predictors of improvement during duloxetine treatment in patients with major depression: an open-label study. | Clinical drug investigation 20110101 |
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy. | Journal of pain research 20110101 |
Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care. | Pain practice : the official journal of World Institute of Pain 20110101 |
Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement? | Annals of general psychiatry 20110101 |
Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. | Pain physician 20110101 |
Retrospective audit on tolerability and efficacy of duloxetine for stress urinary incontinence. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20110101 |
Comparative efficacy of escitalopram in the treatment of major depressive disorder. | Neuropsychiatric disease and treatment 20110101 |
Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation. | Neuropsychiatric disease and treatment 20110101 |
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management. | Breast cancer research : BCR 20110101 |
Novel control by the CA3 region of the hippocampus on neurogenesis in the dentate gyrus of the adult rat. | PloS one 20110101 |
Functional impairment related to painful physical symptoms in patients with generalized anxiety disorder with or without comorbid major depressive disorder: post hoc analysis of a cross-sectional study. | BMC psychiatry 20110101 |
The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. | Arthritis research & therapy 20110101 |
Should we treat depression with drugs or psychological interventions? A reply to Ioannidis. | Philosophy, ethics, and humanities in medicine : PEHM 20110101 |
Serotonin syndrome due to duloxetine. | Clinical neuropharmacology 20110101 |
Postural control in bipolar disorder: increased sway area and decreased dynamical complexity. | PloS one 20110101 |
Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study. | Journal of medical economics 20110101 |
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. | BMC neurology 20110101 |
Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study. | PloS one 20110101 |
Urinary incontinence: pharmacotherapy options. | Annals of medicine 20110101 |
Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States. | Journal of medical economics 20110101 |
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder. | Neuropsychiatric disease and treatment 20110101 |
Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial. | Arthritis research & therapy 20110101 |
Duloxetine-related growth of putamen and brainstem in first-onset drug-naive major depressive disorder with panic disorder: a case series. | The Journal of neuropsychiatry and clinical neurosciences 20110101 |
Duloxetine-induced subcortical growth in a patient with major depressive disorder and panic disorder. | The Journal of neuropsychiatry and clinical neurosciences 20110101 |
Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review. | Journal of pharmacy & bioallied sciences 20110101 |
Pharmacogenetics of antidepressants. | Frontiers in pharmacology 20110101 |
Amebic encephalitis. | Surgical neurology international 20110101 |
Failure to fill electronically prescribed antidepressant medications: a retrospective study. | The primary care companion for CNS disorders 20110101 |
Efficacy of duloxetine and agomelatine does not exceed that of other antidepressants in patients with autistic disorder: preliminary results in 3 patients. | The primary care companion for CNS disorders 20110101 |
Nonsurgical outpatient therapies for the management of female stress urinary incontinence: long-term effectiveness and durability. | Advances in urology 20110101 |
The strategy of combining antidepressants in the treatment of major depression: clinical experience in spanish outpatients. | Depression research and treatment 20110101 |
Dysthymia and apathy: diagnosis and treatment. | Depression research and treatment 20110101 |
The importance of norepinephrine in depression. | Neuropsychiatric disease and treatment 20110101 |
The noradrenergic symptom cluster: clinical expression and neuropharmacology. | Neuropsychiatric disease and treatment 20110101 |
Improvement of the noradrenergic symptom cluster following treatment with milnacipran. | Neuropsychiatric disease and treatment 20110101 |
Migraine with benign episodic unilateral mydriasis. | International journal of general medicine 20110101 |
Antidepressant prescribing and suicides in emilia-romagna region (Italy) from 1999 to 2008: an ecological study. | Clinical practice and epidemiology in mental health : CP & EMH 20110101 |
Duloxetine-induced nocturnal bruxism resolved by buspirone: case report. | Clinical neuropharmacology 20110101 |
Antidepressants: From MAOIs to SSRIs and more. | Indian journal of psychiatry 20110101 |
Sexual dysfunction with the use of antidepressants in a tertiary care mental health setting - a retrospective case series. | Journal of pharmacology & pharmacotherapeutics 20110101 |
Pharmacotherapy for fibromyalgia. | Frontiers in pharmacology 20110101 |
Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. | Frontiers in psychology 20110101 |
Clinical therapeutics in pregnancy. | Journal of biomedicine & biotechnology 20110101 |
Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder. | Patient preference and adherence 20110101 |
Depression in vascular pathologies: the neurologist's point of view. | Vascular health and risk management 20110101 |
Duloxetine in the management of diabetic peripheral neuropathic pain. | Patient preference and adherence 20110101 |
Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study. | Neuropsychiatric disease and treatment 20110101 |
Evaluation of anticonvulsants for possible use in neuropathic pain. | Current medicinal chemistry 20110101 |
Subgroups of older adults with osteoarthritis based upon differing comorbid symptom presentations and potential underlying pain mechanisms. | Arthritis research & therapy 20110101 |
Galactorrhea during duloxetine treatment: a case report. | Turk psikiyatri dergisi = Turkish journal of psychiatry 20110101 |
Update on the management of diabetic polyneuropathies. | Diabetes, metabolic syndrome and obesity : targets and therapy 20110101 |
Trajectory analysis of healthcare costs for patients with major depressive disorder treated with high doses of duloxetine. | Journal of medical economics 20110101 |
Bladder, bowel, and sexual dysfunction in Parkinson's disease. | Parkinson's disease 20110101 |
An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects. | Annals of general psychiatry 20110101 |
Psychotherapy and medication management strategies for obsessive-compulsive disorder. | Neuropsychiatric disease and treatment 20110101 |
Narcolepsy: a review. | Neuropsychiatric disease and treatment 20110101 |
Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders. | Neuropsychiatric disease and treatment 20110101 |
Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine. | BMC psychiatry 20110101 |
Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants. | Molecular pain 20110101 |
Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder. | ClinicoEconomics and outcomes research : CEOR 20110101 |
Duloxetine's effects in resting functional magnetic resonance imaging of first-episode, drug-naive major depressive disorder with panic disorder patients. | The Journal of neuropsychiatry and clinical neurosciences 20110101 |
[Biological age and the pain syndrome at diabetic polyneuropathy]. | Advances in gerontology = Uspekhi gerontologii 20110101 |
Antinociceptive effect of an ethanolic extract of the aerial parts of Hilleria latifolia (Lam.) H. Walt. (Phytolaccaceae). | Journal of pharmacy & bioallied sciences 20110101 |
Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice. | Journal of pharmacy & bioallied sciences 20110101 |
Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment. | Genome medicine 20110101 |
Neuropathic pain: a personal case reflection on a critical incident. | Indian journal of palliative care 20110101 |
Current management of obsessive and phobic states. | Neuropsychiatric disease and treatment 20110101 |
Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: a randomised controlled trial. | Arthritis research & therapy 20110101 |
Generalised anxiety disorder. | BMJ clinical evidence 20110101 |
Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment. | PloS one 20110101 |
Trends in opioid use and dosing among socio-economically disadvantaged patients. | Open medicine : a peer-reviewed, independent, open-access journal 20110101 |
Novel treatment options of binge eating disorder. | Current medicinal chemistry 20110101 |
Severe INR elevation related to duloxetine use: a case report. | Psychosomatics 20110101 |
Hypolipidemic and Antiobesity-Like Activity of Standardised Extract of Hypericum perforatum L. in Rats. | ISRN pharmacology 20110101 |
Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting. | Journal of pain research 20110101 |
Malignant Cerebral Edema following CT Myelogram Using Isovue-M 300 Intrathecal Nonionic Water-Soluble Contrast: A Case Report. | Radiology research and practice 20110101 |
Primary and repeat surgical treatment for female pelvic organ prolapse and incontinence in parous women in the UK: a register linkage study. | BMJ open 20110101 |
Depression screening and patient outcomes in cancer: a systematic review. | PloS one 20110101 |
Phantom limb pain: mechanisms and treatment approaches. | Pain research and treatment 20110101 |
Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid Study. | BMC medical research methodology 20110101 |
Satisfaction with medication is correlated with outcome but not persistence in patients treated with placebo, escitalopram, or serotonin-norepinephrine reuptake inhibitors: a post hoc analysis. | The primary care companion for CNS disorders 20110101 |
Central pain contributions in osteoarthritis: next steps for improving recognition and treatment? | Arthritis research & therapy 20110101 |
Takotsubo cardiomyopathy associated with titration of duloxetine. | Texas Heart Institute journal 20110101 |
Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants. | PloS one 20110101 |
Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid 'reactive depression' in an adolescent. | Pain research & management 20110101 |
Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide. | Journal of neuroinflammation 20110101 |
Circulating and brain BDNF levels in stroke rats. Relevance to clinical studies. | PloS one 20110101 |
Efficacy of duloxetine on painful physical symptoms in major depressive disorder for patients with clinically significant painful physical symptoms at baseline: a meta-analysis of 11 double-blind, placebo-controlled clinical trials. | The primary care companion for CNS disorders 20110101 |
Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial. | Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101 |
Improvement with duloxetine in primary progressive freezing gait. | Neurology 20101207 |
Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. | The journal of pain : official journal of the American Pain Society 20101201 |
A review of SSRIs and SNRIs in neuropathic pain. | Expert opinion on pharmacotherapy 20101201 |
Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. | The Journal of rheumatology 20101201 |
Factors associated with duloxetine treatment among patients with major depressive disorder in Veterans Health Administration: a retrospective study. | Current medical research and opinion 20101201 |
The effect of coadministration of duloxetine on steady-state serum concentration of risperidone and aripiprazole: a study based on therapeutic drug monitoring data. | Therapeutic drug monitoring 20101201 |
False conclusions regarding duloxetine's purported efficacy in pain among depressed patients. | Psychiatria Danubina 20101201 |
Duloxetine. Also avoid its use in recurrent depression. | Prescrire international 20101201 |
Meralgia paresthetica and femoral acetabular impingement: a possible association. | Journal of clinical medicine research 20101201 |
Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain. | Journal of medicinal chemistry 20101111 |
[Mirtazapine-associated hepatotoxicity]. | Medicina clinica 20101106 |
Evaluation of the enantioselectivity of glycogen-based dual chiral selector systems towards basic drugs in capillary electrophoresis. | Journal of chromatography. A 20101105 |
[Effective treatment of depression. Early reduction of painful concomitant symptoms increases the probability of remission]. | MMW Fortschritte der Medizin 20101104 |
[Interview with Dr. Armin Spingler. Management of depression in family practice]. | MMW Fortschritte der Medizin 20101104 |
Artifactual formylation of the secondary amine of duloxetine hydrochloride by acetonitrile in the presence of titanium dioxide: implications for HPLC method development. | Journal of pharmaceutical and biomedical analysis 20101102 |
Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder. | International clinical psychopharmacology 20101101 |
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network. | Alimentary pharmacology & therapeutics 20101101 |
Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis. | Current medical research and opinion 20101101 |
Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials. | Current medical research and opinion 20101101 |
Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir. | The Annals of pharmacotherapy 20101101 |
Analysis of duloxetine hydrochloride and its related compounds in pharmaceutical dosage forms and in vitro dissolution studies by stability indicating UPLC. | Journal of chromatographic science 20101101 |
Duloxetine in major depressed patients resistant to SSRIs and/or venlafaxine. | Psychiatria Danubina 20101101 |
Human health risk assessment of pharmaceuticals in water: issues and challenges ahead. | International journal of environmental research and public health 20101101 |
Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China. | Chinese medical journal 20101101 |
Does the incidence of urgency symptoms increase along with the severity of stress urinary incontinence? | Korean journal of urology 20101101 |
In vitro and in vivo evaluation of the effects of duloxetine on P-gp function. | Human psychopharmacology 20101101 |
Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20101001 |
Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments. | Current medical research and opinion 20101001 |
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olanzapine, and risperidone in patients with psychotic disorders. | Journal of clinical psychopharmacology 20101001 |
A case of milnacipran-related sweating alleviated by duloxetine substitution. | Journal of clinical psychopharmacology 20101001 |
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. | Diabetes care 20101001 |
[The weeping patient]. | MMW Fortschritte der Medizin 20100923 |
Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain. | Bioorganic & medicinal chemistry letters 20100915 |
In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100911 |
The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer. | British journal of cancer 20100907 |
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. | European journal of neurology 20100901 |
Emerging therapies for fibromyalgia: an update. | Expert opinion on emerging drugs 20100901 |
Selective potentiation of gabapentin-mediated antinociception in the rat formalin test by the nicotinic acetylcholine receptor agonist ABT-594. | Neuropharmacology 20100901 |
Duloxetine reduces morphine requirements after knee replacement surgery. | British journal of anaesthesia 20100901 |
Study on the binding of chiral drug duloxetine hydrochloride to human serum albumin. | European journal of medicinal chemistry 20100901 |
Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies. | Current medical research and opinion 20100901 |
Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner. | Anesthesiology 20100901 |
Escitalopram: a review of its use in the management of major depressive disorder in adults. | CNS drugs 20100901 |
Duloxetine for the treatment of fibromyalgia. | Expert review of clinical immunology 20100901 |
Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder. | Psychiatry investigation 20100901 |
Treatment of neuropathic pain. | Seminars in neurology 20100901 |
A case report of Milnacipran in phantom-limb pain. | Asian journal of psychiatry 20100901 |
Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches to rationalize the site of conjugation for thiophene containing drugs. | Chemical research in toxicology 20100816 |
Successful duloxetine treatment of a binge eating disorder: a case report. | Journal of psychopharmacology (Oxford, England) 20100801 |
Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study. | Journal of psychopharmacology (Oxford, England) 20100801 |
Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels. | Journal of psychopharmacology (Oxford, England) 20100801 |
Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression. | Journal of psychopharmacology (Oxford, England) 20100801 |
Analytic model comparing the cost utility of TVT versus duloxetine in women with urinary stress incontinence. | International urogynecology journal 20100801 |
The predictive value of pre-treatment cystometry in the outcome of women with mixed incontinence treated with duloxetine. | European journal of obstetrics, gynecology, and reproductive biology 20100801 |
Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker. | The Journal of pharmacology and experimental therapeutics 20100801 |
Cost-effectiveness of duloxetine: the Stress Urinary Incontinence Treatment (SUIT) study. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100801 |
Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats. | The Journal of urology 20100801 |
Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients. | Drugs & aging 20100801 |
Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20100801 |
Fibromyalgia and bipolar disorder: a potential problem? | Bipolar disorders 20100801 |
Treating diabetic peripheral neuropathic pain. | American family physician 20100715 |
[Evidence-based recommendations for the treatment of fibromyalgia syndrome]. | Zeitschrift fur Rheumatologie 20100701 |
Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis. | International clinical psychopharmacology 20100701 |
Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials. | Expert opinion on drug safety 20100701 |
Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation. | Journal of neurology, neurosurgery, and psychiatry 20100701 |
Duloxetine for the treatment of generalized social anxiety disorder: a preliminary randomized trial of increased dose to optimize response. | CNS spectrums 20100701 |
The treatment of stress incontinence in men: part 2 of a series of articles on incontinence. | Deutsches Arzteblatt international 20100701 |
Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression. | Clinical therapeutics 20100701 |
Urinary incontinence in the elderly: part 3 of a series of articles on incontinence. | Deutsches Arzteblatt international 20100701 |
[Design, synthesis and antidepressive activity of duloxetine derivatives]. | Yao xue xue bao = Acta pharmaceutica Sinica 20100701 |
Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice. | Brain research 20100623 |
Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity. | Bioorganic & medicinal chemistry letters 20100615 |
Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. | Seminars in arthritis and rheumatism 20100601 |
Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot study. | International journal of geriatric psychiatry 20100601 |
Relationship between TSH levels in the normal range and short-term duloxetine efficacy. | Journal of affective disorders 20100601 |
Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery. | Journal of affective disorders 20100601 |
Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients. | Biological psychiatry 20100601 |
Prescription patterns of antidepressants: findings from a US claims database. | Current medical research and opinion 20100601 |
Emerging drugs for treatment of urinary incontinence. | Expert opinion on emerging drugs 20100601 |
Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. | CNS neuroscience & therapeutics 20100601 |
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. | The journal of pain : official journal of the American Pain Society 20100601 |
Medical management of trigeminal neuropathic pains. | Expert opinion on pharmacotherapy 20100601 |
Efficacy and safety of duloxetine in patients with chronic low back pain. | Spine 20100601 |
Update on antithrombotic therapy for stroke prevention in atrial fibrillation. | Current treatment options in cardiovascular medicine 20100601 |
Lymphocytic colitis under treatment with duloxetine. | Zeitschrift fur Gastroenterologie 20100601 |
Pharmacologic management of chronic pain. | The Korean journal of pain 20100601 |
Fibromyalgia syndrome: practical strategies for improving diagnosis and patient outcomes. | The American journal of medicine 20100601 |
Drug treatment of obsessive-compulsive disorder. | Dialogues in clinical neuroscience 20100601 |
Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents. | Experimental neurobiology 20100601 |
Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder. | Psychiatry research 20100530 |
Spinal mechanism of standard analgesics: evaluation using mouse models of allodynia. | European journal of pharmacology 20100525 |
Depression as an initial feature of systemic lupus erythematosus? A case report. | Journal of medicine and life 20100515 |
First preliminary results of a single case report: duloxetine might improve some symptoms of attention-deficit hyperactivity disorder. | European psychiatry : the journal of the Association of European Psychiatrists 20100501 |
Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. | Molecular pharmacology 20100501 |
Urinary flow and urinary symptoms in elderly males exposed to either escitalopram or duloxetine. | Current medical research and opinion 20100501 |
Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study. | International journal of clinical practice 20100501 |
Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20100501 |
Adverse events, toxicity and post-mortem data on duloxetine: case reports and literature survey. | Journal of forensic and legal medicine 20100501 |
Effects of varying degrees of renal impairment on the pharmacokinetics of duloxetine: analysis of a single-dose phase I study and pooled steady-state data from phase II/III trials. | Clinical pharmacokinetics 20100501 |
Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies. | Drug safety 20100501 |
Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. | Expert opinion on pharmacotherapy 20100501 |
Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature. | Expert opinion on pharmacotherapy 20100501 |
Managing diabetic peripheral neuropathic pain in primary care. | The Journal of family practice 20100501 |
Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study. | Pain medicine (Malden, Mass.) 20100501 |
Molecular basis and current treatment for alcoholic liver disease. | International journal of environmental research and public health 20100501 |
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. | British journal of cancer 20100427 |
Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. | Rheumatology (Oxford, England) 20100401 |
New drug treatments for urinary incontinence. | Maturitas 20100401 |
Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective. | Current medical research and opinion 20100401 |
Chronic thromboembolic pulmonary hypertension. | Current treatment options in cardiovascular medicine 20100401 |
[Conservative management of postoperative urinary incontinence in men]. | Der Urologe. Ausg. A 20100401 |
Mixed incontinence: current evidence and future perspectives. | Neurourology and urodynamics 20100401 |
Duloxetine related hypersexuality: a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20100317 |
Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. | Environmental science & technology 20100315 |
Determination of duloxetine hydrochloride in the presence of process and degradation impurities by a validated stability-indicating RP-LC method. | Journal of pharmaceutical and biomedical analysis 20100311 |
1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors. | Journal of medicinal chemistry 20100311 |
[Focus on treatment success of depressed patients. Early and significant pain reduction improves chances for remission]. | MMW Fortschritte der Medizin 20100304 |
Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study. | Journal of psychopharmacology (Oxford, England) 20100301 |
Patient reported outcomes tools in an observational study of female stress urinary incontinence. | Neurourology and urodynamics 20100301 |
Reductions in stress urinary incontinence episodes: what is clinically important for women? | Neurourology and urodynamics 20100301 |
Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. | Biological psychiatry 20100301 |
Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity. | Brain : a journal of neurology 20100301 |
Effects of duloxetine in treatment-refractory men with posttraumatic stress disorder. | Pharmacopsychiatry 20100301 |
Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios. | Drug safety 20100301 |
[The effects of duloxetine on beta-actin stress response in rat brain]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20100301 |
Management of depression in the presence of pain symptoms. | Psychiatria Danubina 20100301 |
Psychiatric pharmacogenomic testing in clinical practice. | Dialogues in clinical neuroscience 20100301 |
Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting. | Psychiatry investigation 20100301 |
The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders. | The journal of pain : official journal of the American Pain Society 20100201 |
Comparison of mechanical allodynia and the affective component of inflammatory pain in rats. | Neuropharmacology 20100201 |
Duloxetine related effects of brain structure on a patient of major depressive disorder with panic disorder. | Progress in neuro-psychopharmacology & biological psychiatry 20100201 |
Tinnitus in postherpetic neuralgia. | The journal of headache and pain 20100201 |
Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats. | Neuroscience research 20100201 |
Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence. | Current medical research and opinion 20100201 |
Duloxetine-modulating effects of brain structure in major depressive disorder with panic disorder. | Journal of clinical psychopharmacology 20100201 |
Duloxetine in the treatment of osteoarthritis knee pain. | Current psychiatry reports 20100201 |
[Treatment of neuropathies]. | Orvosi hetilap 20100110 |
Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland. | Journal of affective disorders 20100101 |
The Arc of synaptic memory. | Experimental brain research 20100101 |
Patient characteristics impacting health state index scores, measured by the EQ-5D of females with stress urinary incontinence symptoms. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100101 |
Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor. | Diabetes care 20100101 |
Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials. | Depression and anxiety 20100101 |
Study on enantiomeric separation of basic drugs by NACE in methanol-based medium using erythromycin lactobionate as a chiral selector. | Electrophoresis 20100101 |
Pharmacological treatment of fibromyalgia syndrome: new developments. | Drugs 20100101 |
Drugs to treat fibromyalgia - the transatlantic difference. | Current opinion in investigational drugs (London, England : 2000) 20100101 |
A case study of salami slicing: pooled analyses of duloxetine for depression. | Psychotherapy and psychosomatics 20100101 |
Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms. | Postgraduate medicine 20100101 |
The market lifecycle of duloxetine for urinary incontinence in Norway. | Acta obstetricia et gynecologica Scandinavica 20100101 |
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. | BMJ (Clinical research ed.) 20100101 |
Expression genetics identifies spinal mechanisms supporting formalin late phase behaviors. | Molecular pain 20100101 |
A closer look at the baseline-observation-carried-forward (BOCF). | Patient preference and adherence 20100101 |
Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat. | PloS one 20100101 |
Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial. | Trials 20100101 |
Medically unexplained pain complaints are associated with underlying unrecognized mood disorders in primary care. | BMC family practice 20100101 |
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease. | Molecular neurodegeneration 20100101 |
A presumed case of phantom limb pain treated successfully with duloxetine and pregabalin. | General hospital psychiatry 20100101 |
Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis. | International journal of medical sciences 20100101 |
Stability-indicating RP-HPLC method development and validation for duloxetine hydrochloride in tablets. | Journal of AOAC International 20100101 |
Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole. | Neuropsychiatric disease and treatment 20100101 |
Continuation treatment of major depressive disorder: is there a case for duloxetine? | Drug design, development and therapy 20100101 |
Reporting bias in medical research - a narrative review. | Trials 20100101 |
Correction of venlafaxine- and duloxetine-induced transaminase elevations with desvenlafaxine in a patient with Gilbert's syndrome. | CNS spectrums 20100101 |
The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy. | Pain practice : the official journal of World Institute of Pain 20100101 |
Practical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorder. | BMC medical research methodology 20100101 |
[Duloxetine in the treatment of chronic migraine]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101 |
Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders. | Health and quality of life outcomes 20100101 |
Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications. | The Journal of neuropsychiatry and clinical neurosciences 20100101 |
Comparison of the consumption of antidepressants in the immigrant and native populations in a Spanish health region: an observational study. | BMC public health 20100101 |
The effect of Neuragen PN on neuropathic pain: A randomized, double blind, placebo controlled clinical trial. | BMC complementary and alternative medicine 20100101 |
The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes. | Neuropsychiatric disease and treatment 20100101 |
Role and rationale for the use of milnacipran in the management of fibromyalgia. | Neuropsychiatric disease and treatment 20100101 |
Hypolocomotion, asymmetrically directed behaviors (licking, lifting, flinching, and shaking) and dynamic weight bearing (gait) changes are not measures of neuropathic pain in mice. | Molecular pain 20100101 |
Atypical depression is more common than melancholic in fibromyalgia: an observational cohort study. | BMC musculoskeletal disorders 20100101 |
Pain response profile of patients with fibromyalgia treated with duloxetine. | The Clinical journal of pain 20100101 |
Stem cell-based neuroprotective and neurorestorative strategies. | International journal of molecular sciences 20100101 |
Fibromyalgia syndrome: a discussion of the syndrome and pharmacotherapy. | American journal of therapeutics 20100101 |
Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. | BMC neurology 20100101 |
Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis. | BMC musculoskeletal disorders 20100101 |
Pregabalin in fibromyalgia--responder analysis from individual patient data. | BMC musculoskeletal disorders 20100101 |
Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. | Arthritis research & therapy 20100101 |
Effect of duloxetine in patients with fibromyalgia: tiredness subgroups. | Arthritis research & therapy 20100101 |
Long lasting pain hypersensitivity following ligation of the tendon of the masseter muscle in rats: a model of myogenic orofacial pain. | Molecular pain 20100101 |
The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature. | International journal of immunopathology and pharmacology 20100101 |
Augmentation of clozapine with aripiprazole in severe psychotic bipolar and schizoaffective disorders: a pilot study. | Clinical practice and epidemiology in mental health : CP & EMH 20100101 |
Perioperative care of an adolescent with postural orthostatic tachycardia syndrome. | Saudi journal of anaesthesia 20100101 |
State-of-the-Art Management of Complications of Myeloma and Its Treatment. | Advances in hematology 20100101 |
Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs. | Primary care companion to the Journal of clinical psychiatry 20100101 |
Duloxetine may improve some symptoms of attention-deficit/hyperactivity disorder. | Primary care companion to the Journal of clinical psychiatry 20100101 |
Ethical issues in scientific publication. | Indian journal of orthopaedics 20100101 |
Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden. | Journal of medical economics 20100101 |
Environmental enrichment induces behavioral recovery and enhanced hippocampal cell proliferation in an antidepressant-resistant animal model for PTSD. | PloS one 20100101 |
[Pharmacologic therapy in peripheral diabetic polyneuropathy]. | Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20100101 |
[Duloxetine]. | Revue de l'infirmiere 20100101 |
A case report of transient but clinically relevant interaction between methadone and duloxetine: a reply to McCance-Katz et al. | The American journal on addictions 20100101 |
Effects of aquajogging in obese adults: a pilot study. | Journal of obesity 20100101 |
Trazodone for the treatment of fibromyalgia: an open-label, 12-week study. | BMC musculoskeletal disorders 20100101 |
An overview of curcumin in neurological disorders. | Indian journal of pharmaceutical sciences 20100101 |
Remission of severe restless legs syndrome and periodic limb movements in sleep after bilateral excision of multiple foot neuromas: a case report. | Journal of medical case reports 20100101 |
Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran. | Neuropsychiatric disease and treatment 20100101 |
Milnacipran: a unique antidepressant? | Neuropsychiatric disease and treatment 20100101 |
Getting the balance right: Established and emerging therapies for major depressive disorders. | Neuropsychiatric disease and treatment 20100101 |
Management of male urinary incontinence. | Indian journal of urology : IJU : journal of the Urological Society of India 20100101 |
Slings in iatrogenic male incontinence: Current status. | Indian journal of urology : IJU : journal of the Urological Society of India 20100101 |
Duloxetine: a review of its pharmacology and use in chronic pain management. | Regional anesthesia and pain medicine 20100101 |
Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression. | La Clinica terapeutica 20100101 |
Efficacy and safety of duloxetine in fibromyalgia. | La Clinica terapeutica 20100101 |
Duloxetine May Improve Tourette's Syndrome: A Case Report. | Primary care companion to the Journal of clinical psychiatry 20100101 |
Alexithymia, emotion processing and social anxiety in adults with ADHD. | European journal of medical research 20100101 |
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors. | Neuropsychiatric disease and treatment 20100101 |
Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. | BMC family practice 20100101 |
Optimal management of perimenopausal depression. | International journal of women's health 20100101 |
Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine. | Journal of medical economics 20100101 |
Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review. | BMC neurology 20100101 |
Duloxetine-related tardive dystonia and tardive dyskinesia: a case report. | General hospital psychiatry 20100101 |
Duloxetine treatment of long-term ketamine abuse-related lower urinary tract symptoms: a case report. | General hospital psychiatry 20100101 |
Proteasome inhibition and its therapeutic potential in multiple myeloma. | Biologics : targets & therapy 20100101 |
Gene expression profile analysis of genes in rat hippocampus from antidepressant treated rats using DNA microarray. | BMC neuroscience 20100101 |
Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. | PloS one 20100101 |
Duloxetine in military posttraumatic stress disorder. | Psychopharmacology bulletin 20100101 |
A new strategy for antidepressant prescription. | Frontiers in neuroscience 20100101 |
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin. | European journal of medical research 20100101 |
Pharmacological treatment of fibromyalgia. | Clinical and experimental rheumatology 20100101 |
Development and validation of a stability-indicating RP-HPLC method for duloxetine hydrochloride in its bulk and tablet dosage form. | Scientia pharmaceutica 20100101 |
3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders. | Scientia pharmaceutica 20100101 |
The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. | Frontiers in neurology 20100101 |
Milnacipran for the management of fibromyalgia syndrome. | Journal of pain research 20100101 |
An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathy. | Journal of pain research 20100101 |
Pregabalin for the management of fibromyalgia syndrome. | Journal of pain research 20100101 |
New and emerging therapeutic agents for the treatment of fibromyalgia: an update. | Journal of pain research 20100101 |
Pilot study: rapidly cycling hypobaric pressure improves pain after 5 days in adiposis dolorosa. | Journal of pain research 20100101 |
Investigational pharmacology for low back pain. | Journal of pain research 20100101 |
Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. | PloS one 20100101 |
Pregabalin in treatment-refractory fibromyalgia. | The open rheumatology journal 20100101 |
Stress degradation studies and kinetic determinations of duloxetine enteric-coated pellets by HPLC. | Journal of AOAC International 20100101 |
Lactating mother and psychotropic drugs. | Mens sana monographs 20100101 |
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine. | Diabetes, metabolic syndrome and obesity : targets and therapy 20100101 |
Challenges in the pharmacotherapy of urogenital disorders. | Frontiers in pharmacology 20100101 |
Research on antidepressants in India. | Indian journal of psychiatry 20100101 |
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver. | Frontiers in pharmacology 20100101 |
Extreme thermal sensitivity and pain-induced sensitization in a fibromyalgia patient. | Pain research and treatment 20100101 |
[Expel the fear of pain. Breaking of chronicity by re-learning]. | MMW Fortschritte der Medizin 20091210 |
Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS. | Journal of pharmaceutical and biomedical analysis 20091205 |
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. | Pain 20091201 |
The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials. | Journal of anxiety disorders 20091201 |
Effects of duloxetine on the pharmacodynamics and pharmacokinetics of warfarin at steady state in healthy subjects. | Journal of clinical pharmacology 20091201 |
Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes. | British journal of pharmacology 20091201 |
How are women with SUI-symptoms treated with duloxetine in real life practice? - preliminary results from a large observational study in Germany. | International journal of clinical practice 20091201 |
Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials. | Expert opinion on pharmacotherapy 20091201 |
Further strategies for treating fibromyalgia: the role of serotonin and norepinephrine reuptake inhibitors. | The American journal of medicine 20091201 |
[Efficacy of escitalopram and severity of depression: new data]. | L'Encephale 20091201 |
[Pharmacological treatment for stress urinary incontinence in prostate cancer]. | Archivos espanoles de urologia 20091201 |
Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin. | Clinical therapeutics 20091201 |
Serotonin syndrome in an octogenarian after switch from fluoxetine to duloxetine. | Journal of the American Geriatrics Society 20091201 |
Association between Painful Physical Symptoms and Clinical Outcomes in Korean Patients with Major Depressive Disorder: A Three-Month Observational Study. | Psychiatry investigation 20091201 |
A treatment algorithm for neuropathic pain: an update. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20091201 |
Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise. | Current neuropharmacology 20091201 |
Duloxetine related binge eating behaviors: a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20091113 |
Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial. | Journal of psychopharmacology (Oxford, England) 20091101 |
Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. | Pain 20091101 |
Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attempt. | The international journal of neuropsychopharmacology 20091101 |
Duloxetine for pathological laughing and crying. | The international journal of neuropsychopharmacology 20091101 |
Use of duloxetine in pregnancy and lactation. | The Annals of pharmacotherapy 20091101 |
What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine. | The Journal of rheumatology 20091101 |
Use of antidepressants for management of hot flashes. | Pharmacotherapy 20091101 |
Painful diabetic neuropathy: advantage of novel drugs over old drugs? | Diabetes care 20091101 |
Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats. | Canadian journal of physiology and pharmacology 20091101 |
Clinical aspects and management of fibromyalgia syndrome. | Annals of the Academy of Medicine, Singapore 20091101 |
Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models. | Brain research 20091027 |
Highly enantioselective Friedel-Crafts reaction of thiophenes with glyoxylates: formal synthesis of duloxetine. | Organic letters 20091015 |
Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters. | Journal of medicinal chemistry 20091008 |
A 52-year-old woman with disabling peripheral neuropathy: review of diabetic polyneuropathy. | JAMA 20091007 |
Duloxetine for treating painful neuropathy or chronic pain. | The Cochrane database of systematic reviews 20091007 |
In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran. | Drug metabolism and disposition: the biological fate of chemicals 20091001 |
Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain. | Diabetes/metabolism research and reviews 20091001 |
Current progress in the pharmacological therapy of fibromyalgia. | Expert opinion on investigational drugs 20091001 |
[Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani]. | L'Encephale 20091001 |
Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20091001 |
Fibromyalgia and myofascial pain syndrome-a dilemma. | Indian journal of anaesthesia 20091001 |
[Combination of dialectic and behavioral therapy (DBT) and duloxetin in kleptomania]. | Psychiatrische Praxis 20090901 |
Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial. | The international journal of neuropsychopharmacology 20090901 |
Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression. | The international journal of neuropsychopharmacology 20090901 |
A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. | European journal of neurology 20090901 |
Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials. | Clinical rheumatology 20090901 |
Successful pain relief of cutaneous leiomyomata due to reed syndrome with the combination treatment of pregabalin and duloxetine. | Journal of pain and symptom management 20090901 |
N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration. | Bioorganic & medicinal chemistry letters 20090901 |
Sexual side-effects of contemporary antidepressants: review. | The Australian and New Zealand journal of psychiatry 20090901 |
Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain. | Journal of medical economics 20090901 |
Medical management of stress urinary incontinence: is there a future? | Current urology reports 20090901 |
Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey. | Pharmacopsychiatry 20090901 |
Duloxetine hydro-chloride. | Acta crystallographica. Section E, Structure reports online 20090901 |
Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse. | European journal of pharmacology 20090815 |
Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test. | Psychopharmacology 20090801 |
[Therapy for urinary incontinence in general practice]. | Aktuelle Urologie 20090801 |
Duloxetine in obese binge eater outpatients: preliminary results from a 12-week open trial. | Human psychopharmacology 20090801 |
Clinicians' views on the NICE guideline on the management of female urinary incontinence. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20090801 |
Fibromyalgia: poorly understood; treatments are disappointing. | Prescrire international 20090801 |
The use of duloxetine in chronic bulimia nervosa: a case report. | Psychiatry (Edgmont (Pa. : Township)) 20090801 |
Stress degradation studies on duloxetine hydrochloride and development of an RP-HPLC method for its determination in capsule formulation. | Journal of chromatographic science 20090801 |
Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids. | Bioanalysis 20090801 |
Duloxetine-induced hypomania: case report and brief review of the literature on SNRIs-induced mood switching. | Journal of psychopharmacology (Oxford, England) 20090701 |
Improvement with duloxetine in an adult ADHD patient. | Journal of attention disorders 20090701 |
Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. | Human psychopharmacology 20090701 |
Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis. | European journal of pharmacology 20090624 |
Duloxetine: in patients with fibromyalgia. | Drugs 20090618 |
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) treatment for Isaacs syndrome with depression. | Progress in neuro-psychopharmacology & biological psychiatry 20090615 |
Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. | Journal of psychiatric research 20090601 |
The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons. | International urogynecology journal and pelvic floor dysfunction 20090601 |
Advances in the management of diabetic peripheral neuropathy. | Current opinion in supportive and palliative care 20090601 |
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. | Journal of clinical psychopharmacology 20090601 |
Serotonin syndrome induced by duloxetine. | The Australian and New Zealand journal of psychiatry 20090601 |
A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia. | The Clinical journal of pain 20090601 |
Total residue analysis of swabs by ion mobility spectrometry. | Analytical chemistry 20090601 |
The psychiatrist confronted with a fibromyalgia patient. | Human psychopharmacology 20090601 |
Fibromyalgia: a complex syndrome requiring a multidisciplinary approach. | Human psychopharmacology 20090601 |
[Clinically relevant drug interactions with new generation antidepressants and antipsychotics]. | Therapeutische Umschau. Revue therapeutique 20090601 |
Psychogenic tremor in a patient with a major depressive episode. | South Dakota medicine : the journal of the South Dakota State Medical Association 20090601 |
[Mechanism of action of new generation antidepressants under development in Japan: focusing on dopamine neurotransmission]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20090601 |
Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials. | CNS spectrums 20090601 |
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. | Clinical therapeutics 20090601 |
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. | Clinical therapeutics 20090601 |
[Treatment of female urinary incontinence]. | MMW Fortschritte der Medizin 20090528 |
4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships. | Bioorganic & medicinal chemistry letters 20090515 |
[Psycho- and pharmacotherapy of depressions. So you combine correctly]. | MMW Fortschritte der Medizin 20090507 |
Severe and symptomatic hyponatremia following duloxetine treatment. | Journal of psychopharmacology (Oxford, England) 20090501 |
Effect of antidepressants on melatonin metabolite in depressed patients. | Journal of psychopharmacology (Oxford, England) 20090501 |
Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090501 |
Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder. | Biological psychiatry 20090501 |
3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20090501 |
Is the significant superiority of escitalopram compared with other antidepressants clinically relevant? | International clinical psychopharmacology 20090501 |
Nontricyclic antidepressants for neuropathic pain #187. | Journal of palliative medicine 20090501 |
Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants. | Clinical therapeutics 20090501 |
Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study. | Clinical therapeutics 20090501 |
Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial. | The Journal of clinical psychiatry 20090501 |
Determination of duloxetine in human plasma by capillary electrophoresis with laser-induced fluorescence detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090415 |
Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization. | Psychopharmacology 20090401 |
Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods. | Human psychopharmacology 20090401 |
Baseline severity of depression predicts antidepressant drug response relative to escitalopram. | Expert opinion on pharmacotherapy 20090401 |
Duloxetine in the management of elderly patients with major depressive disorder: an analysis of published data. | Expert opinion on pharmacotherapy 20090401 |
Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study. | The Journal of clinical psychiatry 20090401 |
[Severe forms of depression: the efficacy of escitalopram]. | L'Encephale 20090401 |
Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: does risk occur with therapeutic doses? | Epilepsy & behavior : E&B 20090401 |
Duloxetine: new indication. In generalised anxiety too? No thanks! No tangible efficacy but numerous and sometimes severe adverse effects. | Prescrire international 20090401 |
Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder. | Journal of affective disorders 20090301 |
Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats. | Neurochemical research 20090301 |
Role of alpha2-adrenoceptors and glutamate mechanisms in the external urethral sphincter continence reflex in rats. | The Journal of urology 20090301 |
Pharmacological assessment of the rat formalin test utilizing the clinically used analgesic drugs gabapentin, lamotrigine, morphine, duloxetine, tramadol and ibuprofen: influence of low and high formalin concentrations. | European journal of pharmacology 20090301 |
[Is medical therapy useful in the management of stress urinary incontinence?]. | Der Urologe. Ausg. A 20090301 |
Solid-phase microextraction using poly(pyrrole) film and liquid chromatography with UV detection for analysis of antidepressants in plasma samples. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090301 |
When worlds collide: urinary incontinence and female sexuality. | The American journal of nursing 20090301 |
Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain. | Indian journal of experimental biology 20090301 |
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. | Lancet (London, England) 20090227 |
Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission. | The Journal of clinical psychiatry 20090210 |
Polydimethylsiloxane/polypyrrole stir bar sorptive extraction and liquid chromatography (SBSE/LC-UV) analysis of antidepressants in plasma samples. | Analytica chimica acta 20090202 |
Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial. | Psychological medicine 20090201 |
Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression. | Journal of psychiatric research 20090201 |
Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD). | Journal of psychiatric research 20090201 |
Postprostatectomy incontinence: all about diagnosis and management. | European urology 20090201 |
A single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis pain. | The journal of pain : official journal of the American Pain Society 20090201 |
A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design. | Journal of clinical psychopharmacology 20090201 |
Duloxetine in the treatment of generalized anxiety disorder. | Expert review of neurotherapeutics 20090201 |
Duloxetine in fibromyalgia: rejection. Marketing authorization rejected and rightly so. | Prescrire international 20090201 |
Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy. | Indian journal of pharmacology 20090201 |
Effective treatment of narcolepsy-cataplexy with duloxetine: a report of three cases. | Sleep medicine 20090101 |
Duloxetine: an emerging evidence for fibromyalgia. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090101 |
Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions. | Journal of diabetes and its complications 20090101 |
Neurobehavioral and genotoxic parameters of duloxetine in mice using the inhibitory avoidance task and comet assay as experimental models. | Pharmacological research 20090101 |
1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20090101 |
Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients. | Current drug safety 20090101 |
Current considerations in the treatment of generalized anxiety disorder. | CNS drugs 20090101 |
Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report. | Cases journal 20090101 |
Early symptom change prediction of remission in depression treatment. | Psychopharmacology bulletin 20090101 |
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. | BMC neurology 20090101 |
Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia. | Health and quality of life outcomes 20090101 |
Escitalopram in the treatment of major depressive disorder: a meta-analysis. | Current medical research and opinion 20090101 |
A validated stability indicating rapid LC method for duloxetine HCl. | Die Pharmazie 20090101 |
Open-label support for duloxetine for the treatment of panic disorder. | CNS neuroscience & therapeutics 20090101 |
Treatment of neuropsychiatric symptoms associated with euthyroid Hashimoto thyroiditis with antidepressants: a case report. | General hospital psychiatry 20090101 |
Patient-assessed versus physician-assessed disease severity and outcome in patients with nonspecific pain associated with major depressive disorder. | Primary care companion to the Journal of clinical psychiatry 20090101 |
[Cymbalta (duloxetine) in the treatment of anxiety-depressive disorders in patients with discirculatory encephalopathy]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101 |
[Cymbalta in the treatment of chronic pain syndromes]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101 |
Escitalopram versus other antidepressive agents for depression. | The Cochrane database of systematic reviews 20090101 |
Insomnia in patients with depression: some pathophysiological and treatment considerations. | CNS drugs 20090101 |
Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation. | Clinical pharmacokinetics 20090101 |
Effect of optically modified polyethylene terephthalate fiber socks on chronic foot pain. | BMC complementary and alternative medicine 20090101 |
Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial. | Trials 20090101 |
Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine. | BMC emergency medicine 20090101 |
Quality of life measurement in antidepressant trials. Is there an added value? | Psychotherapy and psychosomatics 20090101 |
Fibromyalgia: diagnosis and treatment options. | Gender medicine 20090101 |
Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. | General hospital psychiatry 20090101 |
Stress incontinence. | BMJ clinical evidence 20090101 |
Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. | Pain medicine (Malden, Mass.) 20090101 |
Duloxetine: a review of its use in the treatment of generalized anxiety disorder. | CNS drugs 20090101 |
High-dose duloxetine for treatment-resistant obsessive-compulsive disorder: a case report with sustained full remission. | Clinical neuropharmacology 20090101 |
Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine. | Pain practice : the official journal of World Institute of Pain 20090101 |
Update on duloxetine for the management of stress urinary incontinence. | Clinical interventions in aging 20090101 |
Late life depression with cognitive impairment: evaluation and treatment. | Clinical interventions in aging 20090101 |
Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. | The Clinical journal of pain 20090101 |
Duloxetine for the treatment of generalized anxiety disorder: a review. | Neuropsychiatric disease and treatment 20090101 |
Desvenlafaxine in the treatment of major depressive disorder. | Neuropsychiatric disease and treatment 20090101 |
A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients. | BMC health services research 20090101 |
Milnacipran: beyond a role of antidepressant. | Clinical neuropharmacology 20090101 |
Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression. | Neuropsychiatric disease and treatment 20090101 |
Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. | BMJ (Clinical research ed.) 20090101 |
Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: treatment outcomes in patients with comorbid arthritis. | Psychosomatics 20090101 |
Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder. | Neuropsychiatric disease and treatment 20090101 |
More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation. | Indian journal of psychiatry 20090101 |
Switching to duloxetine remits ziprasidone - associated urinary incontinence and improves neuropsychiatric behavior in dementia: possible relationship of incontinence to 5HT2 receptor blockade. | Psychopharmacology bulletin 20090101 |
Jejunal intussusception as an unusual cause of abdominal pain in an adult. | McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students 20090101 |
Serratus muscle stimulation effectively treats notalgia paresthetica caused by long thoracic nerve dysfunction: a case series. | Journal of brachial plexus and peripheral nerve injury 20090101 |
Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
Developments in the scientific and clinical understanding of fibromyalgia. | Arthritis research & therapy 20090101 |
Postgraduate corner: Continuing medical education: Psychopharmacology. | Indian journal of psychiatry 20090101 |
[Serotonin-noradrenalin reuptake inhibitors in the treatment of non-malignant pain syndromes; a systematic review]. | Tijdschrift voor psychiatrie 20090101 |
The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis. | Drug safety 20090101 |
Predictors of premature discontinuation of treatment in multiple disease states. | Patient preference and adherence 20090101 |
Postpartum postural orthostatic tachycardia syndrome in a patient with the joint hypermobility syndrome. | Cardiology research and practice 20090101 |
Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials. | Primary care companion to the Journal of clinical psychiatry 20090101 |
Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability. | Therapeutics and clinical risk management 20090101 |
Duloxetine in treating medically unexplained pain and Raynaud's phenomenon. | The Journal of neuropsychiatry and clinical neurosciences 20090101 |
Desvenlafaxine. | Indian journal of psychiatry 20090101 |
Duloxetine for treatment of male sphincteric incontinence following partial conus medullaris infarction after coronary bypass surgery. | Cases journal 20090101 |
Focus on pain mechanisms and pharmacotherapy in the treatment of fibromyalgia syndrome. | Clinical and experimental rheumatology 20090101 |
Antidepressant drugs for chronic urological pelvic pain: an evidence-based review. | Advances in urology 20090101 |
[A naturalistic study comparing two initial duloxetine dosing strategies in a clinical 'real world' setting]. | Rivista di psichiatria 20090101 |
Duloxetine in the treatment of generalized anxiety disorder. | International journal of general medicine 20090101 |
Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy. | Core evidence 20090101 |
Duloxetine for the management of fibromyalgia syndrome. | Journal of pain research 20090101 |
Long-term sick-leavers with fibromyalgia: Comparing their multidisciplinarily assessed characteristics with those of others with chronic pain conditions and depression. | Journal of multidisciplinary healthcare 20090101 |
Study on fluorescence characteristics of duloxetine hydrochloride. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20081201 |
Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine. | Journal of pain and symptom management 20081201 |
Basal and stress-induced modulation of activity-regulated cytoskeletal associated protein (Arc) in the rat brain following duloxetine treatment. | Psychopharmacology 20081201 |
Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety. | Acta psychiatrica Scandinavica 20081201 |
Antidepressants targeting the serotonin reuptake transporter act via a competitive mechanism. | The Journal of pharmacology and experimental therapeutics 20081201 |
An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects. | Drug metabolism and disposition: the biological fate of chemicals 20081201 |
Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20081201 |
Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia. | Current pain and headache reports 20081201 |
First pregabalin and now duloxetine for fibromyalgia syndrome: closer to a brave new world? | Nature clinical practice. Rheumatology 20081201 |
Antidepressant-induced sweating alleviated by aripiprazole. | Journal of clinical psychopharmacology 20081201 |
Prioritizing future research on off-label prescribing: results of a quantitative evaluation. | Pharmacotherapy 20081201 |
Fibromyalgia coverage uneven despite recent drug approvals. | Managed care (Langhorne, Pa.) 20081201 |
Central sensitisation phenomena in primary headaches: overview of a preventive therapeutic approach. | CNS & neurological disorders drug targets 20081201 |
Treatment strategies to improve and sustain remission in major depressive disorder. | Dialogues in clinical neuroscience 20081201 |
Cellular and molecular mechanisms in the long-term action of antidepressants. | Dialogues in clinical neuroscience 20081201 |
Toward achieving optimal response: understanding and managing antidepressant side effects. | Dialogues in clinical neuroscience 20081201 |
Incomplete response in late-life depression: getting to remission. | Dialogues in clinical neuroscience 20081201 |
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. | Dialogues in clinical neuroscience 20081201 |
Incomplete remission in depression: role of psychiatric and somatic comorbidity. | Dialogues in clinical neuroscience 20081201 |
Newer treatments for fibromyalgia syndrome. | Therapeutics and clinical risk management 20081201 |
Treatment options and patient perspectives in the management of fibromyalgia: future trends. | Neuropsychiatric disease and treatment 20081201 |
Duloxetine in the treatment of generalized anxiety disorder. | Neuropsychiatric disease and treatment 20081201 |
New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine. | Neuropsychiatric disease and treatment 20081201 |
New treatment options in the management of fibromyalgia: role of pregabalin. | Neuropsychiatric disease and treatment 20081201 |
Triple reuptake inhibitors: the next generation of antidepressants. | Current neuropharmacology 20081201 |
Pain, pain, go away: antidepressants and pain management. | Psychiatry (Edgmont (Pa. : Township)) 20081201 |
Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain. | Journal of medicinal chemistry 20081127 |
Multiplicative interactions to enhance gabapentin to treat neuropathic pain. | European journal of pharmacology 20081119 |
Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. | Annals of internal medicine 20081118 |
Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. | Annals of internal medicine 20081118 |
Restless legs syndrome as side effect of second generation antidepressants. | Journal of psychiatric research 20081101 |
The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder. | Current medical research and opinion 20081101 |
Duloxetine and pregabalin: safe and effective for the long-term treatment of fibromyalgia? | Nature clinical practice. Neurology 20081101 |
Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder. | International clinical psychopharmacology 20081101 |
Is duloxetine effective treatment for depression with atypical features? | International clinical psychopharmacology 20081101 |
[Dermatological side effects during therapy with serotonin noradrenaline reuptake inhibitors]. | Der Nervenarzt 20081101 |
Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system. | Journal of psychiatric practice 20081101 |
Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors. | Pain 20081015 |
Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. | Journal of psychiatric research 20081001 |
Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. | Journal of psychiatric research 20081001 |
Duloxetine-associated tachycardia. | The Annals of pharmacotherapy 20081001 |
Duloxetine treatment of social anxiety disorder with comorbid major depression. | Journal of clinical psychopharmacology 20081001 |
Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. | Psychiatric services (Washington, D.C.) 20081001 |
Development and validation of chiral LC method for the enantiomeric separation of duloxetine on amylose based stationary phase. | Journal of chromatographic science 20081001 |
Duloxetine for the treatment of fibromyalgia. | Drugs of today (Barcelona, Spain : 1998) 20081001 |
The role of duloxetine in the treatment of anxiety disorders. | Neuropsychiatric disease and treatment 20081001 |
Miscellaneous. | Indian journal of pharmacology 20081001 |
A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. | Arthritis and rheumatism 20080915 |
Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20080915 |
Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080901 |
Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers. | Psychopharmacology 20080901 |
The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder. | Current medical research and opinion 20080901 |
Effects of different antidepressant treatments on the core of depression. | Dialogues in clinical neuroscience 20080901 |
A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy. | The Journal of clinical psychiatry 20080901 |
An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache. | The Journal of clinical psychiatry 20080901 |
Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. | Current neuropharmacology 20080901 |
Triple reuptake inhibitors: a premise and promise. | Psychiatry investigation 20080901 |
A case of apical ballooning cardiomyopathy associated with duloxetine. | Annals of internal medicine 20080805 |
Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. | Human psychopharmacology 20080801 |
The impact of analytic method on interpretation of outcomes in longitudinal clinical trials. | International journal of clinical practice 20080801 |
Single-blind, randomized, controlled trial of pelvic floor muscle training, electrical stimulation, vaginal cones, and no active treatment in the management of stress urinary incontinence. | Clinics (Sao Paulo, Brazil) 20080801 |
Duloxetine (cymbalta) for fibromyalgia. | The Medical letter on drugs and therapeutics 20080728 |
Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine. | International urogynecology journal and pelvic floor dysfunction 20080701 |
Long-term efficacy of duloxetine in women with stress urinary incontinence. | BJU international 20080701 |
Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats. | American journal of physiology. Renal physiology 20080701 |
Anticholinergic activity of 107 medications commonly used by older adults. | Journal of the American Geriatrics Society 20080701 |
Ex vivo assessment of binding site occupancy of monoamine reuptake inhibitors: methodology and biological significance. | Neuropharmacology 20080701 |
Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials. | International clinical psychopharmacology 20080701 |
Treating depression with SNRIs: who will benefit most? | CNS spectrums 20080701 |
Treatment of comorbid pain with serotonin norepinephrine reuptake inhibitors. | CNS spectrums 20080701 |
Tolerability of serotonin norepinephrine reuptake inhibitor antidepressants. | CNS spectrums 20080701 |
The influence of smoking on the serum level of duloxetine. | Pharmacopsychiatry 20080701 |
Answers to the most common questions about the hepatic safety profile of duloxetine. | Postgraduate medicine 20080701 |
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. | Clinical therapeutics 20080701 |
In vitro stability, potency, and dissolution of duloxetine enteric-coated pellets after exposure to applesauce, apple juice, and chocolate pudding. | Clinical therapeutics 20080701 |
Serious suicide attempt with duloxetine treatment. | Southern medical journal 20080701 |
Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence. | Maturitas 20080620 |
Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors. | Pain 20080601 |
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. | Pain 20080601 |
Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy. | The Annals of pharmacotherapy 20080601 |
[Pharmacological treatment of fibromyalgia syndrome]. | Schmerz (Berlin, Germany) 20080601 |
Compelling or irrelevant? Using number needed to treat can help decide. | Acta psychiatrica Scandinavica 20080601 |
Challenges in using opioids to treat pain in persons with substance use disorders. | Addiction science & clinical practice 20080601 |
[Escitalopram versus serotonin reuptake inhibitors]. | L'Encephale 20080601 |
Wine and drug evaluations: lessons on making comparisons of noninferiority. | Journal of psychopharmacology (Oxford, England) 20080601 |
Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting. | Journal of psychopharmacology (Oxford, England) 20080601 |
A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder. | Journal of psychopharmacology (Oxford, England) 20080601 |
Duloxetine: a new psychopharmacologic treatment option for fibromyalgia? | Current psychiatry reports 20080601 |
Measurement of pain and medication effect in a study of duloxetine. | The Journal of clinical psychiatry 20080601 |
Fibromyalgia syndrome: a relevant recent construction of an ancient condition? | Current opinion in supportive and palliative care 20080601 |
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. | Clinical interventions in aging 20080601 |
New treatment options for fibromyalgia: critical appraisal of duloxetine. | Neuropsychiatric disease and treatment 20080601 |
Narcolepsy: current treatment options and future approaches. | Neuropsychiatric disease and treatment 20080601 |
Pharmacological characterization and gene expression profiling of an L5/L6 spinal nerve ligation model for neuropathic pain in mice. | Neuroscience 20080502 |
A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression. | Journal of affective disorders 20080501 |
BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake. | Cellular and molecular neurobiology 20080501 |
Glossopharyngeal neuralgia with cardiac syncope: an idiopathic case treated with carbamazepine and duloxetine. | European journal of neurology 20080501 |
Pain management in fibromyalgia. | Current opinion in rheumatology 20080501 |
Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine. | International clinical psychopharmacology 20080501 |
Poor neonatal adaptation after in utero exposure to duloxetine. | The American journal of psychiatry 20080501 |
Treatment of seasonal affective disorder with duloxetine: an open-label study. | Pharmacopsychiatry 20080501 |
Hepatic effects of duloxetine-I: non-clinical and clinical trial data. | Current drug safety 20080501 |
Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events. | Current drug safety 20080501 |
Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources. | Current drug safety 20080501 |
At-line quantitative ion mobility spectrometry for direct analysis of swabs for pharmaceutical manufacturing equipment cleaning verification. | Analytical chemistry 20080415 |
Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition. | Bioorganic & medicinal chemistry letters 20080415 |
Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder. | International psychogeriatrics 20080401 |
A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder. | Current medical research and opinion 20080401 |
Human health risk assessments for three neuropharmaceutical compounds in surface waters. | Regulatory toxicology and pharmacology : RTP 20080401 |
Is duloxetine safe and effective for the treatment of overactive bladder? | Nature clinical practice. Urology 20080401 |
Pharmacological treatments of fibromyalgia: do complex conditions need complex therapies? | Drug discovery today 20080401 |
Duloxetine in the treatment of major psychiatric and neuropathic disorders. | Expert review of neurotherapeutics 20080401 |
Escitalopram for the treatment of major depression and anxiety disorders. | Expert review of neurotherapeutics 20080401 |
Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. | Annals of internal medicine 20080318 |
Clinical practice. Urinary stress incontinence in women. | The New England journal of medicine 20080306 |
Noradrenergic neuromodulation of human attention for emotional and neutral stimuli. | Psychopharmacology 20080301 |
Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series. | Journal of psychopharmacology (Oxford, England) 20080301 |
Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. | Analytical chemistry 20080301 |
Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability. | The Journal of clinical psychiatry 20080301 |
Nonsurgical treatment of stress urinary incontinence (SUI): grading of evidence in systematic reviews. | BJOG : an international journal of obstetrics and gynaecology 20080301 |
Duloxetine for premenstrual dysphoric disorder: a pilot study. | Expert opinion on pharmacotherapy 20080301 |
The hepatic safety profile of duloxetine: a review. | Expert opinion on drug metabolism & toxicology 20080301 |
Pharmacological treatment of neuropathic pain in older persons. | Clinical interventions in aging 20080301 |
N,N-Dimethyl-3-(1-naphth-yloxy)-3-(2-thien-yl)propan-1-amine. | Acta crystallographica. Section E, Structure reports online 20080301 |
Successful duloxetine use to prevent venlafaxine withdrawal symptoms. | Progress in neuro-psychopharmacology & biological psychiatry 20080215 |
Duloxetine treatment of Premenstrual Dysphoric Disorder: case reports. | Progress in neuro-psychopharmacology & biological psychiatry 20080215 |
Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors. | Bioorganic & medicinal chemistry letters 20080215 |
Diabetic neuropathy: new strategies for treatment. | Diabetes, obesity & metabolism 20080201 |
[Fibromyalgia syndrome: new developments in pharmacotherapy]. | Zeitschrift fur Rheumatologie 20080201 |
Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK. | Current medical research and opinion 20080201 |
In-tube solid-phase microextraction coupled to liquid chromatography (in-tube SPME/LC) analysis of nontricyclic antidepressants in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080201 |
[Drug treatment for neuropathic pain]. | Presse medicale (Paris, France : 1983) 20080201 |
Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. | Behavioural pharmacology 20080201 |
Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder. | Journal of clinical psychopharmacology 20080201 |
Suicidal ideation associated with duloxetine use: a case series. | Journal of clinical psychopharmacology 20080201 |
Successful treatment of nicotine withdrawal with duloxetine: a case report. | Journal of clinical psychopharmacology 20080201 |
Duloxetine-induced cutaneous adverse reaction. | Journal of clinical psychopharmacology 20080201 |
Successful treatment of chronic fatigue syndrome with duloxetine and trijodthyronine--a case study. | Journal of clinical psychopharmacology 20080201 |
Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function. | Journal of clinical psychopharmacology 20080201 |
Treatment of diabetic neuropathy and neuropathic pain: how far have we come? | Diabetes care 20080201 |
The effect of duloxetine on urethral sphincter morphology. | Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 20080201 |
The treatment of urinary incontinence with Duloxetine. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20080201 |
Epidemiology and treatment of post-stroke depression. | Neuropsychiatric disease and treatment 20080201 |
Effects of milnacipran on binge eating - a pilot study. | Neuropsychiatric disease and treatment 20080201 |
Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data. | Pharmaceutical statistics 20080101 |
Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. | Depression and anxiety 20080101 |
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. | Journal of psychiatric research 20080101 |
Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence. | Neurourology and urodynamics 20080101 |
Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms. | Depression and anxiety 20080101 |
Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder. | Depression and anxiety 20080101 |
Duloxetine as a treatment for stress incontinence--where are we now? | International urogynecology journal and pelvic floor dysfunction 20080101 |
Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence. | European urology 20080101 |
Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. | International urogynecology journal and pelvic floor dysfunction 20080101 |
The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. | International journal of clinical practice 20080101 |
Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis. | Psychotherapy and psychosomatics 20080101 |
Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women. | Clinical pharmacokinetics 20080101 |
Antidepressants as analgesics. | CNS drugs 20080101 |
Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial. | BMC urology 20080101 |
Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan. | Malaria journal 20080101 |
[Toxicity in overdoses with new antidepressive agents. A survey of records shows different severity symptoms for different agents]. | Lakartidningen 20080101 |
In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine. | Clinical pharmacokinetics 20080101 |
Switching to duloxetine from selective serotonin reuptake inhibitor antidepressants: a multicenter trial comparing 2 switching techniques. | The Journal of clinical psychiatry 20080101 |
The use of Duloxetine in the treatment of male stress urinary incontinence. | Wiener medizinische Wochenschrift (1946) 20080101 |
[Management of male urinary incontinence after radical prostatectomy (CTMH AFU 2006-2/5): place of perineal rehabilitation and medical treatment]. | Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080101 |
Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial. | Psychopharmacology bulletin 20080101 |
Fibromyalgia: harmonizing science with clinical practice considerations. | Pain practice : the official journal of World Institute of Pain 20080101 |
Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores. | Arthritis research & therapy 20080101 |
Painful diabetic neuropathy: treatment and future aspects. | Diabetes/metabolism research and reviews 20080101 |
An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. | CNS drugs 20080101 |
Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis. | Psychosomatics 20080101 |
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? | Philosophy, ethics, and humanities in medicine : PEHM 20080101 |
Selecting an appropriate medication for treating neuropathic pain in patients with diabetes: a study using the U.K. and Germany Mediplus databases. | Pain practice : the official journal of World Institute of Pain 20080101 |
[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue]. | L'Encephale 20080101 |
Duloxetine and suicide attempts: a possible relation. | Clinical practice and epidemiology in mental health : CP & EMH 20080101 |
Cognitive-behaviour therapy for patients with Abridged Somatization Disorder (SSI 4,6) in primary care: a randomized, controlled study. | BMC psychiatry 20080101 |
Implications of pain in generalized anxiety disorder: efficacy of duloxetine. | Primary care companion to the Journal of clinical psychiatry 20080101 |
A meta-analysis of the efficacy of fibromyalgia treatment according to level of care. | Arthritis research & therapy 20080101 |
Shock-like sensations associated with duloxetine discontinuation. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101 |
Are SNRIs more effective than SSRIs? A review of the current state of the controversy. | Psychopharmacology bulletin 20080101 |
Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. | BMC neurology 20080101 |
Yeast cell factories for fine chemical and API production. | Microbial cell factories 20080101 |
The history and treatment of a bipolar patient diagnosed with Borna disease virus infection. Case report. | APMIS. Supplementum 20080101 |
The significance of treating somatic symptoms on functional outcome improvement in patients with major depressive disorder: a post hoc analysis of 2 trials. | Primary care companion to the Journal of clinical psychiatry 20080101 |
Antidepressant behavioral effects of duloxetine and amitriptyline in the rat forced swimming test. | Acta cirurgica brasileira 20080101 |
Duloxetine in treatment of refractory chronic tennis elbow: two case reports. | Journal of medical case reports 20080101 |
Urinary retention during combined treatment of postpsychotic depression with duloxetine and olanzapine. | Clinical neuropharmacology 20080101 |
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders. | CNS drugs 20080101 |
Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data. | PharmacoEconomics 20080101 |
A cost-utility comparison of four first-line medications in painful diabetic neuropathy. | PharmacoEconomics 20080101 |
A case of PTSD presenting with psychotic symptomatology: a case report. | Cases journal 20080101 |
The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101 |
Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101 |
Sickle cell trait and priapism: a case report and review of the literature. | Cases journal 20080101 |
[Chronic pain and depression]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101 |
Fibromyalgia: presentation and management with a focus on pharmacological treatment. | Pain research & management 20080101 |
Impaired detrusor contractility due to venlafaxine use. | Indian journal of urology : IJU : journal of the Urological Society of India 20080101 |
Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline. | German medical science : GMS e-journal 20080101 |
Continuing medical education. | Indian journal of psychiatry 20080101 |
Cough up for just a cup of coffee: Pharmacoeconomics of depression. | Indian journal of psychiatry 20080101 |
Development and validation of a HPTLC method for Estimation of Duloxetine Hydrochloride in Bulk Drug and in Tablet Dosage Form. | Indian journal of pharmaceutical sciences 20080101 |
Spectrofluorimetric method for determination of duloxetine hydrochloride in bulk and pharmaceutical dosage forms. | Indian journal of pharmaceutical sciences 20080101 |
A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia. | International journal of general medicine 20080101 |
Estimation of Duloxetine Hydrochloride in Pharmaceutical Formulations by RP-HPLC Method. | Indian journal of pharmaceutical sciences 20080101 |
Preparation of antidepressants for use in preclinical research. | The international journal of neuropsychopharmacology 20071201 |
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. | Biological psychiatry 20071201 |
Dopamine D(1) and D(2) receptor agonism enhances antinociception mediated by the serotonin and noradrenaline reuptake inhibitor duloxetine in the rat formalin test. | European journal of pharmacology 20071201 |
Neurobiology of depression: an integrated view of key findings. | International journal of clinical practice 20071201 |
Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. | Journal of clinical psychopharmacology 20071201 |
Mixed urinary incontinence: continuing to confound? | Current opinion in obstetrics & gynecology 20071201 |
Measurement of duloxetine in blood using high-performance liquid chromatography with spectrophotometric detection and column switching. | Therapeutic drug monitoring 20071201 |
A comparison of initial duloxetine dosing strategies in patients with major depressive disorder. | The Journal of clinical psychiatry 20071201 |
Review of duloxetine in the management of diabetic peripheral neuropathic pain. | Vascular health and risk management 20071201 |
Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease. | Clinical therapeutics 20071201 |
Management of painful diabetic neuropathy: what is new or in the pipeline for 2007? | Current diabetes reports 20071201 |
Response to duloxetine in a depressed, treatment-resistant adolescent female. | Journal of child and adolescent psychopharmacology 20071201 |
Use of antidepressants: expansion beyond depression and anxiety. | Psychiatry (Edgmont (Pa. : Township)) 20071201 |
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20071101 |
Which antidepressants have demonstrated superior efficacy? A review of the evidence. | International clinical psychopharmacology 20071101 |
Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression. | International clinical psychopharmacology 20071101 |
Antidepressant agents for the treatment of chronic pain and depression. | Pharmacotherapy 20071101 |
Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial. | The Journal of clinical psychiatry 20071101 |
Duloxetine-related acute dysphoria. | Psychiatry (Edgmont (Pa. : Township)) 20071101 |
Determination of duloxetine in human plasma by liquid chromatography with atmospheric pressure ionization-tandem mass spectrometry and its application to pharmacokinetic study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071015 |
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors. | The international journal of neuropsychopharmacology 20071001 |
Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials. | Journal of women's health (2002) 20071001 |
Treatment of depression in cancer patients. | Current oncology (Toronto, Ont.) 20071001 |
Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease. | Neuropsychiatric disease and treatment 20071001 |
[Conservative treatment of urinary incontinence]. | MMW Fortschritte der Medizin 20070920 |
[Pharmacotherapy of depression: recent developments]. | Revue medicale suisse 20070919 |
HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901 |
Involvement of reflex urethral closure mechanisms in urethral resistance under momentary stress condition induced by electrical stimulation of rat abdomen. | American journal of physiology. Renal physiology 20070901 |
Characteristics and healthcare costs of patients with fibromyalgia syndrome. | International journal of clinical practice 20070901 |
Triple uptake inhibitors: therapeutic potential in depression and beyond. | Expert opinion on investigational drugs 20070901 |
Duloxetine status. | Pain medicine (Malden, Mass.) 20070901 |
Diabetic peripheral neuropathic pain: recognition and management. | Pain medicine (Malden, Mass.) 20070901 |
Assessing the impact of pharmacologic intervention on the quality of life in diabetic peripheral neuropathic pain and fibromyalgia. | Pain medicine (Malden, Mass.) 20070901 |
Safety profile of treatment in diabetic peripheral neuropathic pain. | Pain medicine (Malden, Mass.) 20070901 |
Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. | Pain medicine (Malden, Mass.) 20070901 |
Painful physical symptoms in depression: a clinical challenge. | Pain medicine (Malden, Mass.) 20070901 |
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain. | Pain medicine (Malden, Mass.) 20070901 |
Efficacy of duloxetine as a migraine preventive medication: possible predictors of response in a retrospective chart review. | Headache 20070901 |
Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants. | Journal of pharmaceutical and biomedical analysis 20070815 |
Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence. | International urogynecology journal and pelvic floor dysfunction 20070801 |
Duloxetine compared with placebo for treating women with symptoms of overactive bladder. | BJU international 20070801 |
The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity. | International journal of clinical practice 20070801 |
Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine. | International journal of clinical practice 20070801 |
Duloxetine--three birds with one stone? | International journal of clinical practice 20070801 |
Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression. | International journal of clinical practice 20070801 |
An overview of stress urinary incontinence treatment in women. | Aging clinical and experimental research 20070801 |
Practical management strategies for the chronic pain patient. | The Journal of family practice 20070801 |
Agomelatine and its therapeutic potential in the depressed patient. | Neuropsychiatric disease and treatment 20070801 |
Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006. | Expert opinion on therapeutic patents 20070801 |
Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. | BMJ (Clinical research ed.) 20070714 |
Duloxetine treatment of stress urinary incontinence in women: effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacy. | European journal of obstetrics, gynecology, and reproductive biology 20070701 |
The effects of duloxetine on urethral function and sphincter morphology. | International urogynecology journal and pelvic floor dysfunction 20070701 |
Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070701 |
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. | British journal of pharmacology 20070701 |
A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder. | Current medical research and opinion 20070701 |
Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants. | The American journal of psychiatry 20070701 |
Manic switching in patients receiving duloxetine. | The American journal of psychiatry 20070701 |
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. | The journal of sexual medicine 20070701 |
Successful treatment of refractory hypochondriasis with duloxetine. | Progress in neuro-psychopharmacology & biological psychiatry 20070630 |
Pharmacological validation of a model of cystitis pain in the mouse. | Neuroscience letters 20070629 |
[Stress urinary incontinence in women--current treatment alternatives]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070628 |
[Medication to treat fibromyalgia?]. | Revue medicale suisse 20070620 |
Pharmacologic treatment in postprostatectomy stress urinary incontinence. | European urology 20070601 |
Development and validation of a liquid chromatography-tandem mass spectrometric method for the determination of the major metabolites of duloxetine in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070601 |
Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil. | Psychiatry and clinical neurosciences 20070601 |
Duloxetine in the treatment of social anxiety disorder. | Journal of clinical psychopharmacology 20070601 |
Recurrent hyponatremia after substitution of citalopram with duloxetine. | Journal of clinical psychopharmacology 20070601 |
Update on pharmacotherapy guidelines for treatment of neuropathic pain. | Current pain and headache reports 20070601 |
Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. | The American journal of psychiatry 20070601 |
Burning mouth syndrome: will better understanding yield better management? | Pain practice : the official journal of World Institute of Pain 20070601 |
Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials. | Current medical research and opinion 20070601 |
Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. | Current medical research and opinion 20070601 |
The effects of supratherapeutic doses of duloxetine on blood pressure and pulse rate. | Journal of cardiovascular pharmacology 20070601 |
Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. | The Journal of clinical psychiatry 20070601 |
Career lifetime advances and key developments: diabetes. | Clinical medicine (London, England) 20070601 |
A validated UV spectrophotometric method for determination of duloxetine hydrochloride. | Die Pharmazie 20070601 |
Current aproach to cancer pain management: Availability and implications of different treatment options. | Therapeutics and clinical risk management 20070601 |
Efficacy and tolerability of duloxetine treatment in elderly patients with major depressive disorder and concurrent anxiety symptoms. | Psychiatry (Edgmont (Pa. : Township)) 20070601 |
Serotonin transporter density and anxiolytic-like effects of antidepressants in mice. | Progress in neuro-psychopharmacology & biological psychiatry 20070509 |
Determination of duloxetine in human plasma via LC/MS and subsequent application to a pharmacokinetic study in healthy Chinese volunteers. | Clinica chimica acta; international journal of clinical chemistry 20070501 |
Tolerability and efficacy of duloxetine in a nontrial situation. | BJOG : an international journal of obstetrics and gynaecology 20070501 |
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial. | International clinical psychopharmacology 20070501 |
Duloxetine treatment of dysthymia and double depression: an open-label trial. | The Journal of clinical psychiatry 20070501 |
Cymbalta and your blood glucose. | Diabetes forecast 20070501 |
Detrusor overactivity successfully treated with duloxetine. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20070501 |
Acute dystonia resulting from abrupt bupropion discontinuation. | Progress in neuro-psychopharmacology & biological psychiatry 20070413 |
N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20070401 |
An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorder. | Journal of clinical psychopharmacology 20070401 |
Is there a place for duloxetine? | Drug and therapeutics bulletin 20070401 |
Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies. | The Journal of clinical psychiatry 20070401 |
Duloxetine in the treatment of major depressive disorder. | Neuropsychiatric disease and treatment 20070401 |
Isolation and characterisation of a phenolic impurity in a commercial sample of duloxetine. | Journal of pharmaceutical and biomedical analysis 20070312 |
Urethrovaginal fistula--a rare complication after the placement of a suburethral sling (IVS). | International urogynecology journal and pelvic floor dysfunction 20070301 |
[Conservative treatment of male stress incontinence]. | Der Urologe. Ausg. A 20070301 |
Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats. | Pharmacology, biochemistry, and behavior 20070301 |
Facial flushing associated with duloxetine use. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301 |
Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain. | Diabetes care 20070301 |
Eosinophilic pneumonia due to duloxetine. | Chest 20070301 |
Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects. | British journal of clinical pharmacology 20070301 |
QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study. | Journal of cardiovascular pharmacology 20070301 |
[Evaluation of women's preferences for the treatment of stress urinary incontinence using the paired comparisons method]. | Archivos espanoles de urologia 20070301 |
Using daily interactive voice response assessments: to measure onset of symptom improvement with duloxetine. | Psychiatry (Edgmont (Pa. : Township)) 20070301 |
Synergistic interactions between the dual serotonergic, noradrenergic reuptake inhibitor duloxetine and the non-steroidal anti-inflammatory drug ibuprofen in inflammatory pain in rodents. | European journal of pain (London, England) 20070201 |
The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study. | The Journal of urology 20070201 |
Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers. | Journal of clinical psychopharmacology 20070201 |
Duloxetine and hyponatremia: a report of 5 cases. | Journal of clinical psychopharmacology 20070201 |
Duloxetine-induced excessive disturbing and disabling yawning. | Journal of clinical psychopharmacology 20070201 |
Duloxetine-induced ultrarapid cycling in an adolescent with bipolar depression. | Journal of clinical psychopharmacology 20070201 |
Emerging treatments for major depression. | Expert review of neurotherapeutics 20070201 |
Treatment options for patients with suboptimal response to surgery for stress urinary incontinence. | Current medical research and opinion 20070201 |
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. | Current medical research and opinion 20070201 |
Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder. | Journal of child and adolescent psychopharmacology 20070201 |
Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan. | Neuropsychiatric disease and treatment 20070201 |
Ziconotide: a review of its pharmacology and use in the treatment of pain. | Neuropsychiatric disease and treatment 20070201 |
Planning and analysis of three-arm non-inferiority trials with binary endpoints. | Statistics in medicine 20070130 |
[Psychiatry]. | Revue medicale suisse 20070117 |
Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain. | Biological psychiatry 20070115 |
Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation. | Depression and anxiety 20070101 |
Use of effect size to determine optimal dose of duloxetine in major depressive disorder. | Journal of psychiatric research 20070101 |
Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. | European urology 20070101 |
Prescribing update: why choose duloxetine for depression? | Issues in mental health nursing 20070101 |
Adjuvant analgesics. | The Medical clinics of North America 20070101 |
Does treatment with duloxetine for neuropathic pain impact glycemic control? | Diabetes care 20070101 |
Protocol for the THREAD (THREshold for AntiDepressants) study: a randomised controlled trial to determine the clinical and cost-effectiveness of antidepressants plus supportive care, versus supportive care alone, for mild to moderate depression in UK general practice. | BMC family practice 20070101 |
The application of evidence-based principles of care in older persons (issue 6): urinary incontinence. | Journal of the American Medical Directors Association 20070101 |
Bleeding gums: duloxetine may be the cause. | Journal of postgraduate medicine 20070101 |
Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy. | Current medical research and opinion 20070101 |
A retrospective pooled analysis of duloxetine safety in 23,983 subjects. | Current medical research and opinion 20070101 |
The efficacy of duloxetine in the treatment of premature ejaculation. | International urology and nephrology 20070101 |
Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial. | BMC health services research 20070101 |
Treatment of psychiatric comorbidities in a patient with becker muscular dystrophy. | Psychosomatics 20070101 |
An acute attack of porphyria in a patient taking duloxetine. | Psychosomatics 20070101 |
Personality styles in patients with fibromyalgia, major depression and healthy controls. | Annals of general psychiatry 20070101 |
An internet survey of 2,596 people with fibromyalgia. | BMC musculoskeletal disorders 20070101 |
Diabetic painful neuropathy: current and future treatment options. | Drugs 20070101 |
Pregabalin and duloxetine for the treatment of neuropathic pain disorders. | Journal of pain & palliative care pharmacotherapy 20070101 |
Risk and predictability of drug interactions in the elderly. | International review of neurobiology 20070101 |
Suicide risk and symptom reduction in patients assigned to placebo in duloxetine and escitalopram clinical trials: analysis of the FDA summary basis of approval reports. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101 |
An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies. | Drug safety 20070101 |
[Urinary incontinence in elderly persons]. | Soins. Gerontologie 20070101 |
Simple options for improving signal detection in antidepressant clinical trials. | Psychopharmacology bulletin 20070101 |
Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. | Clinical drug investigation 20070101 |
Duloxetine: a review of its use in the treatment of major depressive disorder. | CNS drugs 20070101 |
Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians. | Primary care companion to the Journal of clinical psychiatry 20070101 |
Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101 |
A case of obsessive-compulsive disorder responding to duloxetine. | Primary care companion to the Journal of clinical psychiatry 20070101 |
Premature ejaculation: definition and drug treatment. | Drugs 20070101 |
Duloxetine for the management of diabetic peripheral neuropathic pain: response profile. | Pain medicine (Malden, Mass.) 20070101 |
Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes. | Pain medicine (Malden, Mass.) 20070101 |
Pharmacokinetics and tolerability of duloxetine following oral administration to healthy Chinese subjects. | Clinical pharmacokinetics 20070101 |
Duloxetine in the treatment of major depressive disorder: an open-label study. | BMC psychiatry 20070101 |
The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101 |
The effect of duloxetine on primary pain symptoms in Parkinson disease. | Clinical neuropharmacology 20070101 |
Antidepressant behavioral effects of duloxetine and fluoxetine in the rat forced swimming test. | Acta cirurgica brasileira 20070101 |
Duloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter study. | Primary care companion to the Journal of clinical psychiatry 20070101 |
Cognitive Behavioral Therapy versus Short Psychodynamic Supportive Psychotherapy in the outpatient treatment of depression: a randomized controlled trial. | BMC psychiatry 20070101 |
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram). | Neuropsychobiology 20070101 |
Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report. | Journal of medical case reports 20070101 |
Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. | Clinical therapeutics 20070101 |
[Efficacy of duloxetine in the treatment of chronic daily headache]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101 |
[Treatment of chronic back pain with antidepressant cymbalta: an experimental study]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101 |
Male incontinence: Pathophysiology and management. | Indian journal of urology : IJU : journal of the Urological Society of India 20070101 |
Duloxetine for childhood depression with pain and dissociative symptoms. | European child & adolescent psychiatry 20061201 |
Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity. | Neuroscience 20061201 |
Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition. | Neuropharmacology 20061201 |
Antidepressants and sexual dysfunction. | Acta psychiatrica Scandinavica 20061201 |
Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. | Journal of clinical psychopharmacology 20061201 |
A case of hyponatremia induced by duloxetine. | Journal of clinical psychopharmacology 20061201 |
Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine. | Journal of clinical psychopharmacology 20061201 |
Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs. | Anesthesia and analgesia 20061201 |
[Dual acting reuptake inhibitors in the treatment of depression and pain]. | Deutsche medizinische Wochenschrift (1946) 20061201 |
[Duloxetine, a new therapeutic option for diabetic peripheral neuropathic pain]. | Deutsche medizinische Wochenschrift (1946) 20061201 |
New developments in the treatment of urinary incontinence. | Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20061201 |
Antidepressants in the treatment of fibromyalgia. | Neuropsychiatric disease and treatment 20061201 |
Duloxetine treatment for women awaiting continence surgery. | International urogynecology journal and pelvic floor dysfunction 20061101 |
Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect? | International clinical psychopharmacology 20061101 |
EFNS guidelines on pharmacological treatment of neuropathic pain. | European journal of neurology 20061101 |
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain. | The journal of pain : official journal of the American Pain Society 20061101 |
Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations). | Current medical research and opinion 20061101 |
Dyskinesia during treatment with duloxetine. | Pharmacopsychiatry 20061101 |
Treatment of diabetic polyneuropathy: Update 2006. | Annals of the New York Academy of Sciences 20061101 |
[Medication of the month. Duloxetine (Cymbalta)]. | Revue medicale de Liege 20061101 |
Immediate switching from moclobemide to duloxetine may induce serotonin syndrome. | The Journal of clinical psychiatry 20061101 |
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. | Neurology 20061024 |
Duloxetine in the treatment of panic disorder. | The international journal of neuropsychopharmacology 20061001 |
Determination of drug binding to plasma proteins using competitive equilibrium binding to dextran-coated charcoal. | Journal of pharmacokinetics and pharmacodynamics 20061001 |
Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder. | Psychopharmacology 20061001 |
The use of duloxetine for stress incontinence after prostatectomy. | BJU international 20061001 |
Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects. | Prescrire international 20061001 |
A first look at duloxetine (Cymbalta) in a postmortem laboratory. | Journal of analytical toxicology 20061001 |
Comparative effects of clomipramine and duloxetine on detrusor and striated sphincter function in male and female rabbits. | Archivos espanoles de urologia 20061001 |
Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report. | Journal of psychopharmacology (Oxford, England) 20060901 |
Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. | European psychiatry : the journal of the Association of European Psychiatrists 20060901 |
Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat. | International clinical psychopharmacology 20060901 |
Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics. | International clinical psychopharmacology 20060901 |
The effects of serotonin reuptake inhibitors on locomotor activity in gerbils. | Pharmacology, biochemistry, and behavior 20060901 |
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II. | Journal of psychiatric practice 20060901 |
Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy in U.S. Hispanic and majority Caucasian patients. | The Journal of clinical psychiatry 20060901 |
Duloxetine withdrawal seizure. | Psychiatry (Edgmont (Pa. : Township)) 20060901 |
Sample size estimation for the van Elteren test--a stratified Wilcoxon-Mann-Whitney test. | Statistics in medicine 20060815 |
N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor. | Bioorganic & medicinal chemistry letters 20060815 |
Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20060815 |
Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients. | Journal of affective disorders 20060801 |
Facilitatory neuromodulative effect of duloxetine on pudendal motor neurons controlling the urethral pressure: a functional urodynamic study in healthy women. | European urology 20060701 |
The effect of antidepressants on lipid homeostasis: a cardiac safety concern? | Expert opinion on drug safety 20060701 |
Case report: fulminant hepatic failure involving duloxetine hydrochloride. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060701 |
Emerging pharmacological therapies for fibromyalgia. | Current opinion in investigational drugs (London, England : 2000) 20060701 |
[Physical complaints can overlap mental symptoms. Diffuse pain? Think about depression!]. | MMW Fortschritte der Medizin 20060608 |
[Duloxetin effective in depression and pain: high remission rates obtained]. | MMW Fortschritte der Medizin 20060608 |
Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range. | Journal of psychiatric research 20060601 |
Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy. | European urology 20060601 |
Duloxetine for male stress incontinence. | European urology 20060601 |
Management of depression relapse: re-initiation of duloxetine treatment or dose increase. | Journal of psychiatric research 20060601 |
Minimal clinically important differences in Incontinence Quality-of-Life scores in stress urinary incontinence. | Urology 20060601 |
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain. | The journal of pain : official journal of the American Pain Society 20060601 |
New and emerging treatment options for neuropathic pain. | The American journal of managed care 20060601 |
Combined use of ECT with duloxetine and olanzapine: a case report. | The journal of ECT 20060601 |
Future prospects in depression research. | Dialogues in clinical neuroscience 20060601 |
Rating scales in depression: limitations and pitfalls. | Dialogues in clinical neuroscience 20060601 |
Somatic symptoms in depression. | Dialogues in clinical neuroscience 20060601 |
Update on pharmacotherapy guidelines for the treatment of neuropathic pain. | Current pain and headache reports 20060601 |
Duloxetine for neuropathic pain based on recent clinical trials. | Current pain and headache reports 20060601 |
Management of psychiatric comorbidity in fibromyalgia. | Current psychiatry reports 20060601 |
Duloxetine in the context of current needs and issues in treatment of women with stress urinary incontinence. | BJOG : an international journal of obstetrics and gynaecology 20060501 |
What do we know about duloxetine's mode of action? Evidence from animals to humans. | BJOG : an international journal of obstetrics and gynaecology 20060501 |
Initial management of stress urinary incontinence: pelvic floor muscle training and duloxetine. | BJOG : an international journal of obstetrics and gynaecology 20060501 |
Duloxetine in women awaiting surgery. | BJOG : an international journal of obstetrics and gynaecology 20060501 |
Safety and tolerability of duloxetine in women with stress urinary incontinence. | BJOG : an international journal of obstetrics and gynaecology 20060501 |
Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine. | Perspectives in psychiatric care 20060501 |
Prospects for the treatment of depression. | The Australian and New Zealand journal of psychiatry 20060501 |
The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs. | Journal of psychiatry & neuroscience : JPN 20060501 |
Duloxetine 60 mg once daily in the treatment of milder major depressive disorder. | International journal of clinical practice 20060501 |
Duloxetine treatment of major depressive episodes in the course of psychotic disorders. | Pharmacopsychiatry 20060501 |
Duloxetine effective for fibromyalgia in some women. | The Journal of family practice 20060501 |
Recent developments in stress urinary incontinence in women. | Nursing standard (Royal College of Nursing (Great Britain) : 1987) 20060501 |
Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials. | The Journal of clinical psychiatry 20060501 |
Interaction of duloxetine and warfarin causing severe elevation of international normalized ratio. | JAMA 20060405 |
Dissection of an allosteric mechanism on the serotonin transporter: a cross-species study. | Molecular pharmacology 20060401 |
Pharmacological characterisation of place escape/avoidance behaviour in the rat chronic constriction injury model of neuropathic pain. | Psychopharmacology 20060401 |
A dose-finding study of duloxetine based on serotonin transporter occupancy. | Psychopharmacology 20060401 |
Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study. | The British journal of psychiatry : the journal of mental science 20060401 |
Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. | Mayo Clinic proceedings 20060401 |
Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review. | The Journal of clinical psychiatry 20060401 |
Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training. | Clinical therapeutics 20060401 |
Duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion and seizures. | Neurology 20060314 |
Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety. | European journal of obstetrics, gynecology, and reproductive biology 20060301 |
Duloxetine: a new selective and dual-acting antidepressant. | Expert opinion on pharmacotherapy 20060301 |
Acute and long-term administration of citalopram desensitizes alpha2-adrenoceptors in the rat vas deferens. | The Journal of pharmacy and pharmacology 20060301 |
Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy. | Journal of the National Medical Association 20060301 |
Exacerbation of PTSD symptoms with use of duloxetine. | The Journal of clinical psychiatry 20060301 |
Clinical interventions for late-life anxious depression. | Clinical interventions in aging 20060301 |
Medical management of depression. | The New England journal of medicine 20060209 |
Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. | Journal of palliative medicine 20060201 |
Duloxetine in diabetic neuropathy. | Expert opinion on pharmacotherapy 20060201 |
Managing stress urinary incontinence -- a primary care issue. | International journal of clinical practice 20060201 |
[Pharmacologic therapy of depression during pregnancy]. | Recenti progressi in medicina 20060201 |
The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. | Expert opinion on drug safety 20060101 |
Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. | Psychosomatics 20060101 |
Advances in the enantioseparation of second-generation antidepressant drugs by electrodriven methods. | Electrophoresis 20060101 |
Fibromyalgia syndrome: which antidepressant drug should we choose. | Current pharmaceutical design 20060101 |
The combination of duloxetine and bupropion for treatment-resistant major depressive disorder. | Depression and anxiety 20060101 |
Biology and therapy of fibromyalgia. New therapies in fibromyalgia. | Arthritis research & therapy 20060101 |
The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. | Molecular diagnosis & therapy 20060101 |
The latest in treatments for incontinence in women. | Nebraska nurse 20060101 |
Is HCl duloxetine effective in the management of urinary stress incontinence after radical prostatectomy? | Urologia internationalis 20060101 |
Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons. | BMC psychiatry 20060101 |
Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain? | Nature clinical practice. Neurology 20060101 |
The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials. | Primary care companion to the Journal of clinical psychiatry 20060101 |
Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. | Pain medicine (Malden, Mass.) 20060101 |
Pain and psychiatry: a critical analysis and pharmacological review. | Clinical practice and epidemiology in mental health : CP & EMH 20060101 |
Power approximation for the van Elteren test based on location-scale family of distributions. | Journal of biopharmaceutical statistics 20060101 |
Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studies. | Primary care companion to the Journal of clinical psychiatry 20060101 |
Tolerability of amine uptake inhibitors in urologic diseases. | Current drug safety 20060101 |
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. | Pain 20051215 |
Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder. | Journal of affective disorders 20051201 |
Serotonin and depression: a disconnect between the advertisements and the scientific literature. | PLoS medicine 20051201 |
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches. | Journal of clinical psychopharmacology 20051201 |
Moving beyond balance for a better antidepressant. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051201 |
Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051201 |
Duloxetine: new drug. For stress urinary incontinence: too much risk, too little benefit. | Prescrire international 20051201 |
Stress incontinence. | Clinical evidence 20051201 |
Editorial foreword. | Therapeutics and clinical risk management 20051201 |
Duloxetine in the treatment of stress urinary incontinence. | Therapeutics and clinical risk management 20051201 |
Efficacy, tolerability, and safety of duloxetine. | CNS spectrums 20051201 |
[Duloxetine. A new preparation for patients with urinary incontinence]. | Ugeskrift for laeger 20051128 |
[Treatment of urinary incontinence in the elderly woman]. | MMW Fortschritte der Medizin 20051110 |
Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials. | The Annals of pharmacotherapy 20051101 |
Safety and adverse event profile of duloxetine. | Expert opinion on drug safety 20051101 |
[Brief case report. Duloxetine in Cotard syndrome]. | Psychiatrische Praxis 20051101 |
A wee problem. | Nursing standard (Royal College of Nursing (Great Britain) : 1987) 20051101 |
Duloxetine in the treatment of stress urinary incontinence. | Women's health (London, England) 20051101 |
Treatment of fibromyalgia: a changing of the guard. | Women's health (London, England) 20051101 |
High-performance liquid chromatographic method for the simultaneous estimation of the key intermediates of duloxetine. | Talanta 20051031 |
[Pharmacotherapy of stress incontinence]. | Deutsche medizinische Wochenschrift (1946) 20051014 |
Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter. | Psychopharmacology 20051001 |
Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20051001 |
New developments in the management of urinary incontinence. | Minerva ginecologica 20051001 |
Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. | Annals of internal medicine 20050920 |
Duloexetine (Cymbalta) for treatment of major depressive disorder. | American family physician 20050915 |
Duloxetine associated with smoking cessation. | The Annals of pharmacotherapy 20050901 |
SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. | CNS spectrums 20050901 |
Dose-response relationship of recent antidepressants in the short-term treatment of depression. | Dialogues in clinical neuroscience 20050901 |
Stress urinary incontinence in women: review and update on neurological control. | Journal of women's health (2002) 20050901 |
[Place of duloxetine in the treatment of stress urinary incontinence]. | Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20050901 |
Detective work: reading fine print, insurers question studies of drugs; Kaiser's veteran sleuth scours medical-journal articles and sees marketing spin; doctors fear loss of choices. | Wall Street journal (Eastern ed.) 20050824 |
Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder. | Current medical research and opinion 20050801 |
Duloxetine (Cymbalta) for diabetic neuropathic pain. | The Medical letter on drugs and therapeutics 20050801 |
Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder. | Clinical therapeutics 20050801 |
Neurobiology of stress urinary incontinence: new insights and implications for treatment. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20050801 |
Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. | The Cochrane database of systematic reviews 20050720 |
FDA warns that antidepressants may increase suicidality in adults. | BMJ (Clinical research ed.) 20050709 |
alpha(2)-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons. | European journal of pharmacology 20050704 |
Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials. | Human psychopharmacology 20050701 |
Duloxetine vs. placebo in patients with painful diabetic neuropathy. | Pain 20050701 |
Pharmacotherapy for stress urinary incontinence. | Current opinion in urology 20050701 |
Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression. | Journal of affective disorders 20050701 |
Overactive bladder. | Cleveland Clinic journal of medicine 20050701 |
Biotransformations for the production of the chiral drug (S)-Duloxetine catalyzed by a novel isolate of Candida tropicalis. | Applied microbiology and biotechnology 20050601 |
Mixed incontinence. | The Journal of urology 20050601 |
Duloxetine for pain symptoms in patients with major depressive disorder. | Current psychiatry reports 20050601 |
Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. | The Journal of clinical psychiatry 20050601 |
[Management of psychological symptoms and physical symptoms of depression. Rapid re-integration of patients into employment]. | MMW Fortschritte der Medizin 20050517 |
[Dual mechanism of action. Remission of physical symptoms]. | MMW Fortschritte der Medizin 20050517 |
Urinary incontinence: a diverse condition. | The Journal of urology 20050501 |
A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. | The Journal of urology 20050501 |
SIGN guidelines on managing urinary incontinence. | Nursing times 20050501 |
Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms. | Expert opinion on pharmacotherapy 20050501 |
Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. | Journal of clinical psychopharmacology 20050401 |
Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies. | Journal of psychiatric research 20050301 |
The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050301 |
[Drug therapy of female urinary incontinence]. | Der Urologe. Ausg. A 20050301 |
Duloxetine for the treatment of major depressive disorder in older patients. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20050301 |
Duloxetine fights major depressive disorder. | The Nurse practitioner 20050301 |
Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression. | Current medical research and opinion 20050301 |
Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder. | Pharmacotherapy 20050301 |
Duloxetine for management of stress urinary incontinence. | The American journal of geriatric pharmacotherapy 20050301 |
Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant? | Neuropsychiatric disease and treatment 20050301 |
Neonatal brain injury. | The New England journal of medicine 20050224 |
[Stress incontinence. How does the bladder become leakproof again?]. | MMW Fortschritte der Medizin 20050210 |
Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. | Psychopharmacology 20050201 |
Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents. | The Journal of pharmacology and experimental therapeutics 20050201 |
Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. | Neuropharmacology 20050201 |
2004 drug approval highlights: FDA update. | The Nurse practitioner 20050201 |
Antidepressants and antiepileptic drugs for chronic non-cancer pain. | American family physician 20050201 |
Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects. | International journal of clinical pharmacology and therapeutics 20050201 |
[Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]. | MMW Fortschritte der Medizin 20050120 |
Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. | Journal of psychiatric research 20050101 |
Characterization of an allosteric citalopram-binding site at the serotonin transporter. | Journal of neurochemistry 20050101 |
[Medical therapy of urinary incontinence]. | Der Internist 20050101 |
Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features. | BMC psychiatry 20050101 |
Impact of duloxetine on quality of life for women with symptoms of urinary incontinence. | International urogynecology journal and pelvic floor dysfunction 20050101 |
[The effectiveness of antidepressants in the treatment of chronic non-cancer pain--a review]. | Psychiatria polska 20050101 |
The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression. | Current pharmaceutical design 20050101 |
[Change in the point of view]. | Krankenpflege Journal 20050101 |
Cost-effectiveness inferences from bootstrap quadrant confidence levels: three degrees of dominance. | Journal of biopharmaceutical statistics 20050101 |
The level of recognition of physical symptoms in patients with a major depression episode in the outpatient psychiatric practice in Puerto Rico: an observational study. | BMC psychiatry 20050101 |
Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years. | Psychosomatics 20050101 |
Time course of depression-symptom improvement during treatment with duloxetine. | Depression and anxiety 20050101 |
The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy. | American journal of therapeutics 20050101 |
[A challenge]. | Krankenpflege Journal 20050101 |
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. | Pain medicine (Malden, Mass.) 20050101 |
[Depression and pain: novel clinical, neurobiological and psychopharmacological data]. | Psychiatria polska 20050101 |
Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101 |
[Duloxetine (Yentreve) in the general practice test: recommendation by the experts. Effective and tolerable therapy of symptoms in female stress incontinence]. | Krankenpflege Journal 20050101 |
Stress urinary incontinence in women: diagnosis and medical management. | MedGenMed : Medscape general medicine 20050101 |
Treatment of stress urinary incontinence with duloxetine hydrochloride. | Reviews in urology 20050101 |
Duloxetine: a dual reuptake inhibitor. | The Annals of pharmacotherapy 20041201 |
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20041201 |
Modern management of women with stress urinary incontinence. | Ostomy/wound management 20041201 |
Some antipsychotics' effect on suicide; duloxetine's promise for elderly. | Behavioral healthcare tomorrow 20041201 |
[Review of antidepressants from the TCAs to the third generation drugs]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041201 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. | The Journal of pharmacology and experimental therapeutics 20041101 |
Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake. | Bioorganic & medicinal chemistry letters 20041101 |
[Urinary stress incontinence in women]. | Aktuelle Urologie 20041101 |
The brain leads the way. | BJU international 20041101 |
Does the new antidepressant duloxetine (Cymbalta) have any advantages over other antidepressant drugs? | The Harvard mental health letter 20041101 |
Duloxetine hydrochloride. | Nature reviews. Drug discovery 20041101 |
Duloxetine. | Journal of psychiatric practice 20041101 |
Home treatment for women with stress urinary incontinence. | Nursing times 20041101 |
[New options in pharmacological treatment of urinary stress incontinence in women]. | Ceska gynekologie 20041101 |
Molecule of the month. Duloxetine hydrochloride. | Drug news & perspectives 20041101 |
Duloxetine (Cymbalta): a new SNRI for depression. | The Medical letter on drugs and therapeutics 20041011 |
[Pharmaceutical treatment of stress incontinence. New approaches via a direct effect of duloxetine on Onuf's nucleus]. | Der Urologe. Ausg. A 20041001 |
Clinical experience with dual action antidepressants in different chronic pain syndromes. | Human psychopharmacology 20041001 |
Serotonin and noradrenaline reuptake inhibitors in animal models of pain. | Human psychopharmacology 20041001 |
Preview of new drugs for overactive bladder and incontinence: darifenacin, solifenacin, trospium, and duloxetine. | Current urology reports 20041001 |
Pharmacological treatment of women awaiting surgery for stress urinary incontinence. | Obstetrics and gynecology 20040901 |
Balanced treatments for fibromyalgia. | Arthritis and rheumatism 20040901 |
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. | Arthritis and rheumatism 20040901 |
New drugs and dosage forms. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040901 |
Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine. | Clinical therapeutics 20040901 |
Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression. | Drugs of today (Barcelona, Spain : 1998) 20040901 |
Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. | Journal of clinical psychopharmacology 20040801 |
Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20040801 |
Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. | Progress in neuro-psychopharmacology & biological psychiatry 20040801 |
[Duloxetine in the treatment of urinary incontinence in women]. | Minerva ginecologica 20040801 |
[The 10-minute consultation. Urinary incontinence in a woman]. | MMW Fortschritte der Medizin 20040722 |
Synthesis and biological activity of some known and putative duloxetine metabolites. | Bioorganic & medicinal chemistry letters 20040705 |
Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model. | The Journal of pharmacology and experimental therapeutics 20040701 |
New developments in the management of stress urinary incontinence. | BJU international 20040701 |
Role of serotonin and noradrenaline in stress urinary incontinence. | BJU international 20040701 |
Duloxetine: an innovative approach for treating stress urinary incontinence. | BJU international 20040701 |
Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women. | The Journal of urology 20040701 |
Duloxetine's role in the treatment of depression and associated painful physical symptoms. | The Journal of clinical psychiatry 20040701 |
The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence. | American journal of obstetrics and gynecology 20040701 |
New approaches in the pharmacological treatment of stress urinary incontinence. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20040701 |
Targeting serotonin and norepinephrine receptors in stress urinary incontinence. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20040701 |
Duloxetine: a new approach for treating stress urinary incontinence. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20040701 |
Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. | Circulation 20040629 |
Validation of a clinical algorithm to diagnose stress urinary incontinence for large studies. | The Journal of urology 20040601 |
[Update on medical treatment of female stress urinary incontinence]. | Gynecologie, obstetrique & fertilite 20040601 |
[New options in the treatment of various forms of diabetic neuropathy]. | MMW Fortschritte der Medizin 20040520 |
Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers. | British journal of clinical pharmacology 20040501 |
Stress incontinence: help at hand. | BJU international 20040501 |
Stress urinary incontinence in women. | Journal of the American Academy of Nurse Practitioners 20040501 |
The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? | The Journal of clinical psychiatry 20040401 |
Augmentation of milnacipran by risperidone in treatment for major depression. | The international journal of neuropsychopharmacology 20040301 |
Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. | BJOG : an international journal of obstetrics and gynaecology 20040301 |
[Duloxetine and other tricyclic antidepressive agents: pharmacodynamic effects in the lower urinary tract]. | Actas urologicas espanolas 20040301 |
[Successful phase III study with serotonin-noradrenaline reuptake inhibitor. Soon a drug to control stress incontinence]. | MMW Fortschritte der Medizin 20040212 |
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. | Biological psychiatry 20040201 |
Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. | BJU international 20040201 |
Metabolism of the newest antidepressants: comparisons with related predecessors. | IDrugs : the investigational drugs journal 20040201 |
Effect of age on the pharmacokinetics of duloxetine in women. | British journal of clinical pharmacology 20040101 |
Effects of duloxetine on painful physical symptoms associated with depression. | Psychosomatics 20040101 |
Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine. | The Journal of clinical psychiatry 20040101 |
Pharmacotherapy for stress urinary incontinence : present and future options. | Drugs 20040101 |
[Physical recovery is part of remission]. | Krankenpflege Journal 20040101 |
Common pathways of depression and pain. | The Journal of clinical psychiatry 20040101 |
Reboxetine: a norepinephrine selective reuptake pump inhibitor. | Journal of psychiatric practice 20040101 |
The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials. | BMC psychiatry 20040101 |
[Clinical management of patients with depression and cardiac disease]. | Vertex (Buenos Aires, Argentina) 20040101 |
Duloxetine: in stress urinary incontinence. | Drugs 20040101 |
[FDA approval for the antidepressive drug Cymbalta]. | Krankenpflege Journal 20040101 |
Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label study. | BMC geriatrics 20040101 |
SNRIs in the management of acute major depressive disorder. | The Journal of clinical psychiatry 20040101 |
[Stress incontinence in general practice]. | Krankenpflege Journal 20040101 |
[Duloxetine reduces pain and depression]. | Krankenpflege Journal 20040101 |
[Duloxetine receives positive recommendation by the Scientific Committee of EMEA for treatment of depression]. | Krankenpflege Journal 20040101 |
New tools 2004. | Diabetes self-management 20040101 |
[Duloxetin--a new tool in pharmacotherapy of urinary incontinence in women]. | Urologiia (Moscow, Russia : 1999) 20040101 |
[Urinary incontinence: new pharmacologic therapies]. | Revista de medicina de la Universidad de Navarra 20040101 |
Newer antidepressants in the primary care setting. | Primary care companion to the Journal of clinical psychiatry 20040101 |
Duloxetine: a new pharmacologic therapy for stress urinary incontinence. | Reviews in urology 20040101 |
Duloxetine: a summary of published clinical experience. | Reviews in urology 20040101 |
Management of stress urinary incontinence. | Reviews in urology 20040101 |
Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake. | Bioorganic & medicinal chemistry letters 20031215 |
Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats. | Neuropharmacology 20031201 |
Innovations in pharmacotherapy for stress urinary incontinence. | International urogynecology journal and pelvic floor dysfunction 20031201 |
Physical symptoms comorbid with depression and the new antidepressant duloxetine. | Journal of psychosocial nursing and mental health services 20031201 |
Update on overactive bladder: pharmacologic approaches on the horizon. | Current urology reports 20031001 |
Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. | The Journal of urology 20031001 |
Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence. | Urology 20031001 |
Serotonergic modulation of bladder afferent pathways. | Urology 20031001 |
Pharmacologic treatment of stress urinary incontinence: expectations for outcome. | Urology 20031001 |
Duloxetine in the long-term treatment of major depressive disorder. | The Journal of clinical psychiatry 20031001 |
A word of caution about the implied role for duloxetine in pain management. | The Journal of clinical psychiatry 20031001 |
Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030901 |
Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. | Drug metabolism and disposition: the biological fate of chemicals 20030901 |
Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence. | Expert opinion on investigational drugs 20030901 |
Role of 5-HT receptors in treatment of overactive bladder. | Drugs of today (Barcelona, Spain : 1998) 20030801 |
Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. | Obstetrics and gynecology 20030701 |
Validation of two global impression questionnaires for incontinence. | American journal of obstetrics and gynecology 20030701 |
Duloxetine: a review. | Expert review of neurotherapeutics 20030701 |
Enhancement of antidepressant potency by a potentiator of AMPA receptors. | Cellular and molecular neurobiology 20030601 |
Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence. | BJU international 20030501 |
Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers. | Clinical pharmacology and therapeutics 20030301 |
Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. | Naunyn-Schmiedeberg's archives of pharmacology 20030301 |
Dual monoamine modulation for improved treatment of major depressive disorder. | Journal of clinical psychopharmacology 20030201 |
[Depression also effects the body]. | Pharmazie in unserer Zeit 20030101 |
Analgesic effects of antidepressants. | The Journal of clinical psychiatry 20030101 |
New hope in the treatment of painful symptoms in depression. | Current opinion in investigational drugs (London, England : 2000) 20030101 |
Physical symptoms of depression: unmet needs in special populations. | The Journal of clinical psychiatry 20030101 |
The development of new antidepressants: focus on duloxetine and escitalopram. | Harvard review of psychiatry 20030101 |
Duloxetine in treatment of anxiety symptoms associated with depression. | Depression and anxiety 20030101 |
Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder. | The Journal of clinical psychiatry 20030101 |
Pharmacological agents used for the treatment of stress urinary incontinence in women. | Current medical research and opinion 20030101 |
CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. | Drugs 20030101 |
[Duloxetine and other tricyclic antidepressants: pharmacodynamic effects in the lower urinary tract]. | Actas urologicas espanolas 20030101 |
[18 million sick days due to depressive illnesses. New prospects in therapy of depression]. | Krankenpflege Journal 20030101 |
Current and future pharmacological treatment for overactive bladder. | The Journal of urology 20021101 |
Comparison of the thermogenic and hypophagic effects of sibutramine's metabolite 2 and other monoamine reuptake inhibitors. | European journal of pharmacology 20020927 |
Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats. | Life sciences 20020802 |
Duloxetine Eli Lilly. | Current opinion in investigational drugs (London, England : 2000) 20020801 |
Duloxetine versus placebo in the treatment of stress urinary incontinence. | American journal of obstetrics and gynecology 20020701 |
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. | Pharmacology, biochemistry, and behavior 20020401 |
Somatic symptoms, depression, and antidepressant treatment. | The Journal of clinical psychiatry 20020401 |
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. | The Journal of clinical psychiatry 20020401 |
Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. | The Journal of clinical psychiatry 20020301 |
Circling behavior induced by microinjection of serotonin reuptake inhibitors in the substantia nigra. | Pharmacology, biochemistry, and behavior 20020101 |
Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype? | Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques 20020101 |
Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. | Journal of psychiatric research 20020101 |
Duloxetine pharmacology: profile of a dual monoamine modulator. | CNS drug reviews 20020101 |
Duloxetine for the treatment of major depressive disorder. | Psychopharmacology bulletin 20020101 |
Can monoamine-based therapies be improved? | The Journal of clinical psychiatry 20020101 |
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011201 |
[Serotonin-noradrenaline reuptake inhibitors(SNRIs)]. | Nihon rinsho. Japanese journal of clinical medicine 20010801 |
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010501 |
Lack of effectiveness of combined 5-fluorouracil and leucovorin in patients with 5-fluorouracil-resistant advanced colorectal cancer. | European journal of cancer & clinical oncology 19890101 |